1CURRICULUM VITAELast updated May 16, 2023

Abraham A. Palmer, Ph.D.Professor and Vice Chair for Basic Research

Department of PsychiatryUniversity of California San Diego

Mail Code 0667Biomedical Research Facility II (BRF2) Room; 3A24

9500 Gilman Dr.La Jolla, CA 92093-0667

orcid.org/0000-0003-3634-0747 http://www.palmerlab.orghttp://www.ratgenes.org

aap@ucsd.edu @AbePalmer

Summary

My research examines the influence of genes on behavior and reflects my training in behavioral neuroscience, molecular biology, pharmacology and quantitative genetics. I am currently pursuing research projects that use mice, rats, and humans. A major focus of my work has been on developing and refining methods for genome wide association studies (GWAS) in model organisms and integrating these results with expression QTLs (eQTL) to identify specific and testable hypotheses about the relationship between genes and behavior. My work with humans focuses on intermediate phenotypes, such as amphetamine sensitivity and delay discounting. My lab is currently studying several genes that we identified using these methods with the goal of gaining novel mechanistic and biological insights (e.g. Glo1, Cadm2, Gpm6b). Education1988-1991 B.A. Biology, University of Chicago1993-1999 Ph.D. Biomedical Sciences, University of California San Diego

Positions and Appointments1989-1991 Laboratory Technician with Dr. Lewis S. Seiden, University of Chicago1991-1993 Staff Research Associate with Dr. William F. Ganong, UC San Francisco1993-1999 Graduate Student with Dr. Morton P. Printz, UC San Diego1999-2002 Postdoctoral Fellow with Dr. Tamara J. Phillips, Oregon Health & Sciences University2002-2003 Postdoctoral Fellow with Dr. T. Conrad Gilliam, Columbia University2003-2005 Associate Research Scientist, Columbia University2005-2012 Assistant Professor of Human Genetics (Primary), University of Chicago2006-2012 Assistant Professor of Psychiatry and Behavioral Neuroscience (Secondary)2005-current Member Committee on Genetics, Genomics and System Biology 2006-current Member Committee on Neurobiology2006-current Member Committee on Clinical Pharmacology and Pharmacogenomics2006-current Member, J. P. Kennedy Mental Retardation and Developmental Disabilities Center 2012-2015 Associate Professor of Human Genetics, University of Chicago (with tenure)2012-2014 Associate Professor of Psychiatry and Behavioral Neuroscience (Secondary)2014-2015 Associate Professor of Psychiatry and Behavioral Neuroscience (co-primary)2015-2106 Member, Institute for Genomics & Systems Biology, University of Chicago (IGSB)2015-2016 Professor of Human Genetics, University of Chicago (co-primary)2015-2016 Professor of Psychiatry and Behavioral Neuroscience, University of Chicago (co-primary)2015-2016 Director, Center for Quantitative Behavioral Genetics, University of Chicago2016-current Professor of Psychiatry, University of California San Diego2016-current Member, Institute for Genomic Medicine, University of California San Diego

2016-current Vice Chair for Basic Research, Department of Psychiatry, University of California San Diego2018-current Member of the UCSD Center for Microbiome Innovation (CMI)2018-current Member of the Halicioğlu Data Science Institute (HDSI)

Professional Memberships1992-current American Association for the Advancement of Science (AAAS)1993-current Society for Neuroscience (SFN)1999-2001 Research Society on Alcoholism (RSA)2001-current International Behavioral Neurogenetics Society (IBANGS)2003-current Complex Trait Community (CTC)2006-2007 International Behavioral Neuroscience Society (IBNS)2006-current American Society of Human Genetics (ASHG)2006-current International Mammalian Genome Society (IMGS)2011-2014 Associate Member of American College of Neuropsychopharmacology (ACNP)2014-current Member of American College of Neuropsychopharmacology (ACNP)2013-current Member of International Society for Psychiatric Genetics (ISPG)

Honors and Awards1988 National Merit Scholarship, Semi-Finalist1993 National Science Foundation Pre-Doctoral Fellowship, Honorable Mention1996 PhRMA Pre-Doctoral Fellowship, Competitive Nomination2000 Research Society on Alcoholism Junior Investigator Award2001 Research Society on Alcoholism Junior Investigator Award2002 OHSU Department of Behavioral Neuroscience Annual Best Paper Award2002 OHSU School of Medicine Annual Best Paper Award Runner-Up2005 American College of Neuropsychopharmacology (ACNP) selected for “Hot Topics” symposium2006 International Behavioral and Neural Genetics Society Travel Award2007 IBANGS Junior Faculty Outstanding Young Investigator Award2009 IBANGS Young Scientist Award2011-2014 Associate Member of American College of Neuropsychopharmacology (ACNP)2014-current Member of American College of Neuropsychopharmacology (ACNP)2019 Fellow of the International Behavior and Neural Genetics Society (IBANGS; honorific)

Honors and Awards to my Students2005 Scholarship, Short Course on Complex Trait Analysis Scholarship, Jax Labs (Christine Ponder)2005 Scholarship, Symposium on Emotion, Health Emotions Research Institute (Christine Ponder)2006 IBANGS Graduate Student Outstanding Travel Award, Vancouver, BC (Christine Ponder)2008 IBANGS Outstanding Postdoc Student Travel Award, Portland, OR (Camron Bryant)2009 Best Poster Award, Biomedical Sciences Retreat (Margaret Distler)2009 IBANGS Postdoc Travel Award (Clarissa Parker)2010 Uniformed Services University Amygdala Conference Travel Award (Clarissa Parker)2010 First Place, Graduate Student Symposium, Chicago Society for Neuroscience (Margaret Distler)2010 Graduate Student Travel Award Fellowship, Society for Neuroscience (Margaret Distler)2011 IBANGS Outstanding Graduate Student Travel Award (Amy Hart) 2011 Abstract chosen for “Selected Talks Session” at Genes, Brain & Behavior Meeting, Rome, Italy

(Camron Bryant) 2011 Abstract chosen for “Selected Talks Session” at Genes, Brain & Behavior Meeting, Rome, Italy

(Margaret Distler)2011 American College of Neuropsychopharmacology (ACNP) Early Career Travel Award (3 year all-

expenses paid trip to annual meeting; Camron Bryant) 2011 International Narcotics Research Conference (INRC) Travel Award (Camron Bryant)2011 Travel Award for NIDA Miniconvention, “Frontiers in Addiction Research” (Camron Bryant)2011 ACNP Travel Awardee Breakout Session, Waikaloa Beach, Hawaii, Dec 4-8 (Camron Bryant)2012 Gordon Conferences on Genes and Behavior Travel Award (Natalia Gonzales)

2

2012 IBANGS Travel Award Fellowship (Camron Bryant, Clarissa Parker, Amy Hart and Natalia Gonzales)

2012 Jackson Laboratory Genetics of Addiction Tuition Fee Waiver (Clarissa Parker)2012 American College of Neuropsychopharmacology Young Investigator Travel Award (Clarissa

Parker)2012 Genes, Brain and Behavior Postdoctoral Travel Award (Laura Sittig)2012 NIDA-INSERM Workshop on US-France Collaboration on Drug Abuse and Addiction Travel

Award (Laura Sittig)2012 GSA Travel Fund Award for travel to World Congress on Psychiatric Genetics (WCPG) in

Hamburg, Germany (Amy Hart)2012 American College of Neuropsychopharmacology (ACNP) Early Career Travel Award (3 year all-

expenses paid trip to annual meeting; Clarissa Parker)2013 Naomi Ragins-Goldsmith Career Development Award (Margaret Distler)2013 Alpha Omega Alpha Honor Medical Society (Margaret Distler)2013 CTC Chicago Travel Award (Natalia Gonzales)2013 Epstein Trainee Award; American Society of Human Genetics (Shyam Gopalakrishnan)2013 JAX Genetics of Addiction Short Course Scholarship (Natalia Gonzales)2014 Selected for 2014 Senior Scientific Session (honorary selection; Margaret Distler)2014 UCLA Statistical Genetics Short Course Diversity Fellowship (Natalia Gonzales)2014 CTC Best Graduate Student Poster (Natalia Gonzales)2014 AAAS/Science Program for Excellence in Science (Natalia Gonzales)2014 IBANGS Travel Award (Natalia Gonzales, Margaret Distler, Katherine McMurray, Celine St.

Pierre & Alex Gileta)2014 Outstanding Postdoc Travel Award Winner (30 min oral presentation), IBANGS (Laura Sittig)2014 Graduation from Pritzker School of Medicine MD/PhD program with Honors (Margaret Distler) 2014 John Van Prohaska Award for outstanding potential in teaching, research, and clinical medicine

(Margaret Distler)2014 The Leon O. Jacobson Prize, granted to the MD/PhD student whose basic science research is

judged to be the most meritorious from among session participants; Senior Scientific Session, Pritzker School of Medicine (Margaret Distler)

2014 IMGS Award for Outstanding Poster Presentation (Natalia Gonzales)2014 IMGS Travel Scholarship (Natalia Gonzales)2015 Gordon Research Conference on Quantitative Genetics Travel Award (Natalia Gonzales) 2015 IMGS Award for Outstanding Oral Presentation (Natalia Gonzales)2015 IMGS Travel Scholarship (Natalia Gonzales)2015 Travel Award for the Short Course on the Genetics of Addiction (Alex Gileta)2015 Rat Genetics & Genomics for Psychiatric Disorders and Addiction – Best Poster Award

(Katherine McMurray and Alex Gileta) 2015 USDA Animal Genetics Conference Grant (Natalia Gonzales)2015 Research Society on Alcoholism Travel Award (Katherine McMurray) 2016 Research Society on Alcoholism Student Merit Travel Award (Amanda Barkley-Levenson)2016 ACNP Postdoc Travel Award for American College of Neuropsychopharmacology (Laura Sittig)2017 IBANGS Young Investigator Travel Awards, Madrid, Spain (Sandra Sanchez-Roige and

Amanda Barkley-Levenson)2017 Outstanding Presentation Award at 15th annual CTC meeting (Camron Bryant)2017 World Congress of Psychiatric Genetics travel award (Sandra Sanchez-Roige)2017 Oral Presentation Finalist, World Congress of Psychiatric Genetics (Sandra Sanchez-Roige)2017 The Interdisciplinary Research Fellowship in NeuroAIDS (Sandra Sanchez-Roige)2018 ACNP Postdoc Travel Award (Sandra Sanchez-Roige)2018 NARSAD Young Investigator Award (Sandra Sanchez-Roige)2018 ACNP Harry June Award (Sandra Sanchez-Roige)

Fellowships and Grants to my students 2008-2009 F32 NIDA Postdoc Fellowship “Translational Genetics and Dopamine Signaling in Sensitivity to

Amphetamines” (Camron Bryant)

3

2011-2016 K99/R00 NIDA “Genetic Basis of Opioid Reward and Aversion in Mice” (Camron Bryant)2013 NARSAD Young Investigator Grant, “Genome-wide Association for Conditioned Fear in the

Diversity Outbred Mouse Population” (Clarissa Parker)2014 NARSAD Young Investigator Grant “From Statistical to Biological Epistasis in Mental Illness:

Gene Expression as a Bridge” (Laura Sittig)2014 F32 NIMH Postdoc Fellowship “Mapping epistatic modifiers of human psychiatric risk using

mouse genetics” (Laura Sittig)2014 F31 NIDA Predoc Fellowship “Integrative genetic analysis of methamphetamine’s motivational

effects in mice” F31DA036358 (Natalia Gonzales) 2015 F31 NIDA Predoc Fellowship “GWAS for the attribution of incentive salience in outbred rats”

F31DA039638 (Alex Gileta)2016 F32 NIAAA Postdoc Fellowship “Epistatic modifiers and novel genetic contributions to binge-

like drinking and motivational effects of alcohol” F32AA025515 (Amanda Barkley-Levenson)2016 NARSAD Young Investigator Grant “Identifying cell-type specific chromatin changes induced by

maternal immune activation: Implications for schizophrenia” (Kayla Chase)2016 Frontiers of Innovation Scholars Program (FISP) “Does genetic predisposition to choose

immediate rewards alter health outcomes? A genome/phenome-wide association study using electronic medical records” (Sandra Sanchez-Roige)

2018 NARSAD New Investigator Award “CADM2, a cell adhesion molecule, and its association with risk and psychopathology” (Sandra Sanchez-Roige)

2019 Tobacco Related-Disease Research Program (TRDRP) “Elucidating the genetic basis of nicotine dependence by using electronic health records” (Sandra Sanchez-Roige)

Active Grants

Active Grants: PI

2017-2022 NIDA U01 “Identification of genetic variants that contribute to compulsive cocaine intake in rats” U01DA043799; Role: MPI with Olivier George, Total Costs $3,793,220

2014-2024 NIDA P50 “Integrated GWAS of complex behavioral and gene expression traits in outbred rats” P50DA037844; Role: PI of Center, PI of Cores A, C, D and Project 4; Total Costs for 2019-2024 $14,474,800

2017-2020      Tobacco Related Disease Research Program (TRDRP) High Impact Award “Genetic relationship between impulsivity and nicotine abuse” Award number 588289; Role: PI; Total Costs: $935,550

2018-2023      NIAAA R01 “A novel pharmacotherapy for alcoholism: evaluation of reward, aversion, compulsivity, withdrawal & reinstatement” R01AA026281; Role: PI; Total costs: $1,929,375

Active Grants: co-I

2018-2023      NEY R01 “Genetic Modulators of Glaucoma” R01EY021200; (PI Monica Jablonski); Role: coI; Total costs: $1,535,975

2018-2023      NIDA U01 “Genomic analysis of avoidance learning in addiction”; (PI: Tom Jhou); U01DA044468; Role: coI (PI of subcontract); Total costs: $3,266,317

2018-2023      NIDA U01 “Identification of genetic features of delay discounting using a heterogeneous stock rat model”; (PI: Suzanne Mitchell); U01DA046077; Role: coI (PI of subcontract); Total costs: $2,534,899

2018-2023      NIDA U01 “The Genetic Basis of Opioid Dependence Vulnerability in a Rodent Model”; (PI: Peter Kalivas); U01DA045300; Role: coI Total costs: $4,116,085

2018-2023      NIDA U01 “Use of Next-Gen Sequencing to Identify Genetic Variants that Influence compulsive Oxycodone Intake in Outbred Rats”; (PI: Olivier George); U01DA044451; Role: coI (PI of subcontract); Total costs: $3,623,977

2017-2022      NIDA U01 “Genetics of novelty seeking and propensity for drug abuse in outbred rats”; (PI: Huda Akil and Jun Li); U01DA043098; Role: coI (PI of subcontract); Total costs: $3,304,426

2017-2021      NIAMS R01 “Identification of Genes Regulating Bone Matrix Composition and Quality”; (PI: Douglas Adams, University of Colorado); R01AR070879; Role co-I; Total costs: $2,343,964

2016-2019      NIDA R15 “Genome-wide association for affective withdrawal in outbred mice”; (PI: Clarissa Parker, Middlebury College); Role: co-I; R15DA041618; Total costs: $320,000

4

Completed GrantsCompleted Grants: PI

2000-2001 N.L. Tartar Research Fellowship “Disruption of Circadian Rhythm, a Modulator of Ethanol Preference and Consumption?” Role: PI; Direct Costs $2,000

2001-2002 NIAAA F32 Individual NRSA Postdoctoral Fellowship “Ethanol and Allopregnanolone: Common Genetic Influences?” F32AA05600; Role: PI; Direct Costs $30,186

2003-2009 NIMH K01 “Translational Genetic Study of Fear and Anxiety” K01MH70933; Role: PI; Direct Costs $415,020.

2003-2005 NARSAD 2003 Young Investigator Award “Gene Expression Changes Following Chronic Fluoxetine in Serotonin and CRH Mutant Mice” Role: PI; Direct Costs $60,000

2006-2008 Schweppe Foundation Career Development Award, “Translational Genetic Study of Stimulant Sensitivity” Role: PI; Direct Costs $100,000

2006-2008 NARSAD 2005 Young Investigator Award “Genetic Studies of Fear Learning in Mice and Humans” Role: PI; Direct Costs $60,000

2006-2007 Brain Research Foundation “Development of siRNA microinjections to evaluate candidate genes for behavioral phenotypes”; Role: PI; Direct Costs $25,000

2006-2011 NIDA R01 “Mouse QTL and Human Association Study of Methamphetamine Sensitivity” R01DA021336; Role: PI; Direct Costs $1,225,743 (competitively renewed in 2011)

2007-2013 NIMH R01 "Finding genes that cause QTL for fear learning and anxiety" R01MH079103; Role: PI; Direct Costs $1,216,984

2008-2010 NIDA R21 "Novel Methods to Map Stimulant QTLs in Advanced Intercross Lines" R21DA024845; Role: PI; Direct Costs $275,000

2009-2011 NIDA R03 "Weighted genome-wide association study of amphetamine sensitivity in humans" R03DA027545; Role: PI; Direct Costs $300,000

2011-2017 NIDA R01 “Systems genetic analysis of methamphetamine's motivational effects in a mouse AIL” R01DA021336 Role: PI; Total Costs $2,174,256 (renewal)

2011-2013 NIDDK P60 (Internal pilot grant) “Role of Glo1 in the pathophysiology of diabetes” Pilot and Feasibility Award DRTC P60DK020595; Role: PI; Direct Costs $60,000

2012-2013 Conte Center Pilot Project P50 (Internal pilot grant) “human impulsivity and delay discounting” Role: PI; Direct Costs $20,000

2013-2014 NIDDK P60 (Internal pilot grant) “Mapping epistatic modifiers of diabetes using the Akita mouse model of pancreatic beta cell stress” Pilot and Feasibility Award DRTC P60DK020595; Role: PI; Direct Costs $30,000

2011-2015 NIGMS R01 “Genome-wide association studies in outbred mice” R01GM097737 Role: PI; Total Costs $1,942,921

2013-2015 NIMH R21 “Efficient discovery of epistatic modifiers of Cacna1c in mice: extending on GWAS” R21MH102728; Role: PI; Total Costs $434,500

2013-2015 NIMH T32 “Training in Emerging Multidisciplinary Approaches to Mental Health and Disease” T32MH020065; Role: PI; Total Costs $1,140,131

2014-2015 (Supplement to R01DA021336); Role: PI; Direct Costs: $63,2912014-2017 NIDA R21 “GWAS for goal versus sign tracking in genetically heterogeneous rats”

R21DA036672 Role: PI; Total Costs: $444,8572014-2019 NIDA P50 “Integrated GWAS of complex behavioral and gene expression traits in outbred rats”

P50DA037844; Role: PI of Center, PI of Cores A, C, D and Project 4; Total Costs for 2014-2019 $12,597,279 (competitively renewed in 2019)

Completed Grants: co-I

2009-2011 NIDA R21 “Is Ecstasy an Empathogen? Effects of MDMA on Social and Emotional Processing” R21DA026570 Role: co-I (PI: Harriet de Wit, University of Chicago)

2010-2012 Unilever “Psychoactive Constituents in Chocolate: The effects of Theobromine and Caffeine on Mood and Cognition in human: Analysis of Genotypic Differences” Role: co-I (PI: Harriet de Wit, University of Chicago)

2008-2013 NINDS R01 "Genetics of Mouse Seizure Susceptibility" R01NS061991; Role: co-I (PI: Melodie Winawer, Columbia University)

5

2009-2014 NIAMS R01 “Genetic Variation of Muscle Mass” R01AR056280; Role: co-I (PI: David Blizzard, Penn State)

2014-2016 NIMH R21 “Identifying genes interacting with BTBD3 to regulate obsessive-compulsive phenotypes” R21MH104829; Role co-I (PI: Stephanie Dulawa, University of Chicago)

2011-2017 NIDA R01 “The genetic basis of impulsive behavior in humans” R01DA032015; Role co-I (PI: Harriet de Wit, University of Chicago)

2015-2017 Advancing a Healthier Wisconsin: Research for a Healthier Tomorrow, “Genetic mapping and gene identification in acute kidney injury using outbred rats”; Role co-I (PI: Leah Solberg Woods, Medical College of Wisconsin)

Completed Training Grant Support

1993-1996 NIGMS NRSA Pre-Doctoral Training Grant T31GM077521996-1999 NHLBI NRSA Pre-Doctoral Training Grant T31HL072611999-2001 NIAAA NRSA Post-Doctoral Training Grant T32AA074682002-2003 New York State Foundation for Mental Hygiene Research Associate

Training Grants2006-2013 Training Faculty, Multidisciplinary Psychiatric Genetics Training Program (T32MH200065)2006-2013 Training Faculty, Neuropsychopharmacology Training for Drug Abuse Research

(T32DA007255)2006-2015 Training Faculty, Training in Neural Systems (T32GM007839)2006-2015 Training Faculty, Committee on Clinical Pharmacology and Pharmacogenomics

(5T32GM007019)2006-2015 Training Faculty, Genetics and Regulation (T32GM007197)2006-2015 Training Faculty, Graduate Training in Growth and Development (T32HD007009)2006-2015 Training Faculty, Medical Scientist National Research Service Award (T32GM007281)2007-2009 Executive Committee, Training in Neural Systems (T32GM007839) 2009-2012 Student Advising Committee, Training in Neural Systems (T32GM007839)2010-2015 Admissions Committee, Medical Scientist National Research Service Award (T32GM007281)2011-2013 Executive Committee, Multidisciplinary Psychiatric Genetics Training Program (T32MH200065)2012-2013 Executive Committee, Training in Neural Systems (T32GM007839)2013-2015 PI/Program Director, Training in Emerging Multidisciplinary Approaches to Mental Health and

Disease (T32MH200065)2016-current Training Faculty, Genetics Training Program, UCSD (T32GM008666)2016-current Training Faculty, Fellowship in Biopsychiatry and Neuroscience, UCSD (T32MH018399)

Graduate Student Training Activities and Committees2005 Molecular Biosciences Cluster, Admissions Committee for Human Genetics2006 Website Redesign Committees for Committee on Genetics and Molecular Biosciences Cluster2006 Molecular Biosciences Cluster, Chair of Human Genetics Admissions Committee 2007-2010 Human Genetics Graduate Program, Curriculum Committee 2009 Committee on Neurobiology Annual Retreat Planning Committee2010 Molecular Biosciences Graduate Program Retreat Committee2010-2015 Divisional Committee on Graduate Teaching Assistants2011-2012 Human Genetics Graduate Program Admissions Committee2012-2015 Graduate Minority Committee 2013-2015 Human Genetics Awards Committee2013 Committee on Neurobiology Annual Retreat Planning Committee2013-2015 Chair of Graduate Student Advisory Committee for the Committee on Neurobiology2016-current Member Biomedical Sciences Graduate Program, UCSD2016-current Neurosciences Graduate Program, UCSD

Teaching at University of Chicago (2005-2015)The College (B.A., B.S.)

2006-2007 Lecturer, Genetics of Model Organisms (BIOS21236)

6

2007 Lecturer, Behavioral Genetics (BIOS11120)2007 Lecturer, Programming for Modern Biological Science Research (BIOS20250)2007-2015 Lecturer, Animal Models in Human Disease (BIOS25126)2008 Co-director and Lecturer, Genetics of Model Organisms (BIOS21236)2009-2015 Course Director and Lecturer, Genetics of Model Organisms (BIOS21236)2011-2015 Lecturer, Genetics (BIOS20182)

Pritzker School of Medicine (M.D.)

2008-current Lecturer, Neuroscience course for Psychiatric residents (PGY3)

Graduate Programs (Ph.D.)

2005-2015 Lecturer, Introduction to Research (MGCB31900)2006-2015 Lecturer, Introduction to Faculty Research (NURB 32000)2007-2012 Lecturer, Multidisciplinary Approaches to Psychiatric and Behavioral Genetics (PSCR46900)2008 Lecturer, Experimental Approaches in Quantitative Ecological Genetics (EVOL43200)2006-2007 Lecturer, Genetic Analysis of Model Organisms (MGCB31400)2008-2015 Lecturer, Perspectives in Drug Abuse Research (NURB32900)2008 Co-director and Lecturer, General Principals of Genetic Analysis (MGCB31400)2009-2015 Course Director and Lecturer, General Principals of Genetic Analysis (MGCB31400)2013-2015 Course Director, Training in Emerging Multidisciplinary Approaches to Mental Health and

Disease (HGEN48000)2014-2015 Lecturer, Scientific Integrity and the Ethical Conduct of Research (BSDG 55000)2014-2015 Lecturer, Senior Graduate Student Ethics (MGCB 32100)2015 Panel member: “How to talk to your PI about careers”

Teaching at University of California San Diego (2016-current) 2016 Lecturer, Fellowship in Biological Psychiatry and Neuroscience Seminar (T32MH018399)2017 Lecturer, COGS 169, “Genetic Information for Behavior: From Single Cells to Mammals”2017 Lecturer, BGGN223, “UCSD Biology Graduate Genetics”2017 Lecturer, BIOM252, “Human genetics and genomics: Underpinnings of human disease and

disease susceptibility”2017 Lecturer, “Scientific Ethics”2017 Course organizer (2 hr/wk for 10 weeks), NEU221, “Quantitative Behavioral Genetics” 2018 Lecturer, COGS169 “Behavioral Genetics”2018 Lecturer, BIOM242, “Scientific ethics”2018 Lecturer, “Addictions Seminar” which is a required course for Dr. Susan Tapert’s T322019 Poster Judge, Genetics Training Program retreat, March 262019 Lecturer, UCSD Medical Scientist Training Program Interdepartmental Lecture Series, August 6

Teaching at Other Institutions 2008 Teacher, "Future of Biology" Summer Outreach Course for High School Teachers2008 Teacher “NIDA Short Course on Genetics and Epigenetics”, Washington, DC 2009 Guest Teacher, “Genetics”, Cold Spring Harbor Labs2010-2012 Co-Organizer of “Short Course on the Genetics of Addiction”, The Jackson Labs, Bar Harbor,

ME, August 14-18, 2010; August 14-19, 2011, August 18-23, 2012 (funded by HHMI and a NIDA R13 meeting grant).

2015 Lecturer, “Human Genetics and Genomics for Life Science Professionals”, Northwestern University, May 11

2015 Instructor, “Genetics of Addiction” for the Cold Spring Harbor Labs Course “Cellular Biology of Drug Addiction”, August 4-10

Public Outreach Events2017-2019 Station Leader, Family Science Night, La Jolla Elementary School (annual event)2017-current Organizer and speaker for honors biology students from Sweetwater High (annual event).2018 Speaker, Taste of Science, Liberty Station, San Diego, CA, April 26, 20182018 Presentation at La Jolla High School for honors biology class, Rachel Tenenbaum, host

7

University Committees and Service (University of Chicago 2005-2015)2006-2009 Organizer, Department of Human Genetics Seminar Series2006-2011 Faculty Host, Faculty Round Table for Sophomores in the Biological Sciences Division2009-2012 Burton-Judson and Breckenridge (Undergraduate Dorms) Faculty Fellow2010-2013 College Council 2014-2015 Steering Committee, Grossman Institute for Neuroscience, Quantitative Biology and Human

Behavior2015 Chair, Warder Clyde Allee Lecture Committee

University Committees and Service (UCSD 2016-current)2016-current Vice Chair for Basic Research, Department of Psychiatry 2016-current co-chair, Department of Psychiatry Research Council2016-current Member, Department of Psychiatry Education & Training Council 2016-current Member, Department of Psychiatry Grand Rounds Committee 2017-current Member, Department of Psychiatry Basic Psychiatry Research Committee2018-current Member, UCSD Health Sciences Research Council2019-current Member, Chair Search Committee for Department of Psychiatry2019-current Member, Department of Psychiatry Space Committee2019-current Member, Department of Psychiatry Finance Committee

External and Scientific Advisory Boards and Committees2012-2015 External Advisory Board (EAB) “Integrative Neurosciences Initiative on Alcoholism: Stress,

Anxiety and Excessive Drinking” (U01AA013641).2014-current External Advisory Board (EAB) “Boris Centre for Addictions Research,” Department of

Psychiatry and Behavioural Neurosciences, McMaster University and St. Joseph’s Healthcare Hamilton

2016-current External Advisory Board (EAB) for NIDA P50 Center of Excellence for Systems Neurogenetics of Addiction (CSNA) at The Jackson Laboratory

2017 Community Representative, Alliance for Genetic Resources, Bethesda, MD, March 7, 20172017-current Scientific Advisory Board (SAB), Rat Genome Database (RGD; rgd.mcw/edu) 2019-current External Advisory Board (EAB), Mouse Genome Database (MGD; mgd.jax.org)2019-2021 Program Advisory Committee (PAC) for Portland Alcohol Research Center (PARC, NIAAA P60

AA010760) 2019-current Scientific Advisory Board (SAB) for Vivid Genomics

Service for Scientific Organizations 2008-2011 Member at Large (nominated and elected), International Behavioral and Neural Genetics

Society (IBANGS)2008-2013 Executive Committee, Complex Trait Community2007-2009 Councilor, Chicago Chapter of the Society for Neuroscience2009 Built Website for International Behavioral and Neural Genetics Society (www.IBANGS.org)2010-2012 Awards Committee for IBANGS (www.IBANGS.org)2012-2015 President Elect/President/Past President of IBANGS (www.IBANGS.org) 2014-2017 Member of the ACNP Public Information Committee

Meetings Organized2010 Organizer of Complex Trait Consortium (CTC) Meeting from May 7-10, 2010 in Chicago, IL.

This meeting was attended by 187 people. Invited speakers: Trudy MacKay, Jonathan Flint, Nancy Cox, Jonathan Pritchard and Kari Stefansson; I was the primary organizer; I coordinated all aspects of the fund raising, meeting planning and execution.

2015 Local host and co-organizer of NIDA meeting “Rat Genetics and Genomics for Psychiatric Disorders and Addiction”, June 29, 2015, Chicago, IL.

2018 Local Host, NIDA Genetics Consortium Meeting, La Jolla, CA, June 16, 20182019 Organizer of Complex Trait Consortium (CTC) meeting at UCSD June 9-11, 2019

Program Committees for National and International Meetings 8

2010 Complex Trait Consortium meeting, Chicago, Illinois2011 Program Committee, Gene Brain and Behavior 13th Annual Meeting, Rome, Italy2014 Program Committee, 16th Annual Meeting of the International Behavioural and Neural Genetics

Society, May 10-132016-2019 World Congress on Psychiatric Genetics (WCPG)2018-2020 American College of Neruopsychopharmacology (ACNP) Program Committee2019 Complex Trait Consortium meeting, La Jolla, CA2019-current Research Society on Alcoholism (RSA) Program Committee2019 ACNP Program Committee 2021 Summer Meeting Workgroup

Grant Review Study Sections2006 National Science Foundation Grant Review, Oct 15 (email review)2009 Special Emphasis Panel/Scientific Review Group ZRG1, PA-08-149, Review of NIMH R13

Meeting Grants, Feb 17 (Phone meeting)2009 Special NIH Study Section GXM-A (05) RFA titled “Interactions between Physical Activity and

Drug Abuse”, Washington, DC, June 2-32009 Special Emphasis Panel/Scientific Review Group ZMH1 ERB-C (A3) S meeting, Review of

ARRA “GO” grants, June 29 (Phone meeting)2009 The Wellcome Trust, 090710, November 2 (email review)2009 National Institute on Drug Abuse (NIDA)’s Cutting-Edge Basic Research Awards (CEBRA)

program, November 17-20 (Phone meeting)2010 The Wellcome Trust (email review)2011 NIH study section (ad hoc) Genetics of Health and Disease (GHD), Chicago, IL, Oct 24-252012 The Wellcome Trust, April 16th (email review)2012 NIH study section (ad hoc) Genetics of Health and Disease (GHD), Washington DC, June 28-292012 Site visit, NHGRI Centers of Excellence in Genomic Science (CEGS), University of North

Carolina, Chapel Hill, Aug 24, 2013.2013 French National Research Agency (ANR), February, 2013 (email review).2013 Special Emphasis Panel/Scientific Review Group ZRG1, March (phone meeting).2014 NIDA ZDA1 LXF L, January 7 (phone meeting)2014 NIDA ZDA1 JXR-G, April 24 (phone meeting)2014 GGG-L P01 study section, July 9 (phone meeting)2014 NIDA ZDA1 JXR-D, July 9-10 (phone meeting)2014 NIDA ZDA1 JXR-G, November 25 (phone meeting)2015 NIDA ZDA1 JXR-G, January 22 (phone meeting)2017 NIMH ZRG1 IFCN-Z, June 6 (phone meeting)2018 NIDA Avenir Awards, January 31 (phone) and March 21 (in person, Washington DC)2019 U-M Precision Health Investigators Awards

Ad Hoc Reviewing for JournalsAlcohol, Alcoholism Clinical and Experimental Research (ACER); Archives of General Psychiatry; Behavior Genetics; Behavioural Brain Research; Behavioral Neuroscience; Behavioural Processes; Biochemical Pharmacology; Biological Psychiatry; Brain, Behavior, and Immunity; Brain Research; Brain Research Bulletin; Cell; European Neuropsychopharmacology; Gene; Genes, Brain and Behavior (G2B); Genetics; Genome Research; Journal of Clinical Investigation (JCI); Journal of Neurochemistry; Journal of Neuroscience; Journal of Psychiatric Research; Mammalian Genome; Molecular Psychiatry, Nature Methods; Nature Genetics, Nature Neuroscience, Neurobiology of Learning and Memory; Neuropharmacology; Neuropsychopharmacology (NPP); Neuroscience; The Neuroscientist; Pharmacogenetics and Genomics; Pharmacology, Biochemistry and Behavior (PB&B); Psychiatry Research; Psychoneuroendocrinology; Physiology & Behavior; Physiological Genomics; PLoS Genetics (also occasional ‘Guest Associate Editor’); PLoS ONE; Proceedings for the National Academy of Science (PNAS); Psychopharmacology; Science, Science Advances.

Editorial Roles for Journals2010-2019 Associate Editor for Genes, Brain and Behavior

9

2010-current Associate Editor for Frontiers in Neurogenetics 2010-2019 Associate Editor for PLoS ONE2010-2014 Associate Editor for Frontiers in Genetics of Complex Traits2012-current Associate Editor for Frontiers in Behavioral and Psychiatric Genetics 2012-2013 Associate Editor for BMC Genomics2013-2019 Editorial Board, Current Behavioral Neuroscience Reports2014-current Associate Editor for Genetics

PatentsWO2014159720 “Methods and Compositions for inhibiting Glyoxalase 1” (GLO1); (Pending).

Original Peer Reviewed Research 1. Walker CD, Dallman MF, Palmer AA, Steele MK. Involvement of central corticotrophin-releasing factor

(CRF) in suckling-induced inhibition of luteinizing hormone secretion in lactating rats. J Neuroendocrinol, 1993, 5:451

2. Palmer AA, Steele MK, Shackelford RL, Ganong WF. Intravenous losartan inhibits the increase in plasma luteinizing hormone and water intake produced by intraventricular angiotensin II. Proc Soc Exp Biol Med, 1994, 205:263

3. Klett CPR, Palmer AA, Gallagher AM, Rioseco-Camacho N, Printz MP. Differences in cultured cardiac fibroblast populations isolated from SHR and WKY rats. Clin Exp Pharmacol and Physiol, 1995:S265

4. Klett CPR, Palmer AA, Dirig DM, Gallagher AM, Rioseco-Camacho N, Printz MP. Evidence for differences in cultured left ventricular fibroblast populations isolated from spontaneously hypertensive and wistar-kyoto rats. J Hypertens, 1995, 13:1421

5. Palmer AA, Printz MP. Attenuation of airpuff startle induced Fos expression following tympanic membrane rupture. Brain Res, 1998, 787:91

6. Grove KL, Speth RC, Palmer AA, Ganong WF, Steele MK. Angiotensin II receptor binding sites in the ventral portion of the bed nucleus of the stria terminalis are reduced by interruption of the medial forebrain bundle. Brain Res, 1998, 809:5

7. Palmer AA, Printz MP. Strain differences in Fos expression following airpuff startle in SHR and WKY rats. Neuroscience, 1999, 89:965

8. Palmer AA, Printz MP. Airpuff startle reflex strain differential Fos expression in young SHR and WKY. Clin Exp Hypertens, 1999, 21:1061

9. Palmer AA, Dulawa SC, Mottiwala AA, Geyer MA, Printz MP. Prepulse startle deficit in the Brown Norway rat: a potential genetic model. Behav Neurosci, 2000, 114:374

10. Lessov CN, Palmer AA, Quick EA, Phillips TJ. Voluntary ethanol drinking is altered in ethanol sensitized C57BL/6J, but not DBA/2J mice. Psychopharmacology, 2001, 115:91

11. Conti LH, Palmer AA, Vanella JJ, Printz MP. Latent inhibition and conditioning in inbred rats that show differential prepulse inhibition. Behav Genet, 2001, 31:325

12. Palmer AA, Miller MA, McKinnon CS, Phillips TJ. Sensitivity to the locomotor stimulant effects of ethanol and allopregnanolone is influenced by common genes. Behav Neurosci, 2002, 116:126

13. Palmer AA, Printz MP. Expression of fos protein in RVLM projecting neurons following airpuff startle in SHR and WKY rats: origins of sympathetic response to environmental stimuli. Clin Exp Hypertens, 2002, 24:125

14. Palmer AA, Moyer MR, Crabbe JC, Phillips TJ. Initial sensitivity, tolerance and cross-tolerance to allopregnanolone- and ethanol-induced hypothermia in selected mouse lines. Psychopharmacology, 2002, 162:313

15. Pandori MW, Hobson DA, Olejnik J, Krzymanska-Olejnik E, Rothschild KJ, Palmer AA, Phillips TJ, Sano T. Photochemical control of the infectivity of adenoviral vectors using a novel photocleavable biotinylation reagent. Chem Biol, 2002, 9:567

16. Phillips TJ, Shen EH, McKinnon CS, Burkhart-Kasch S, Lessov CN, Palmer AA. Forward, relaxed and reverse selection for reduced and enhanced sensitivity to ethanol's locomotor stimulant effects in mice. Alcohol Clin Exp Res, 2002, 26:593

17. Palmer AA, Phillips TJ. Effect of forward and reverse selection for ethanol-induced locomotor response on

10

other measures of ethanol sensitivity. Alcohol Clin Exp Res, 2002, 26:132218. Palmer AA, McKinnon CS, Bergstrom HC, Phillips TJ. Locomotor activity responses to ethanol, other

alcohols, and GABA-A acting compounds in forward- and reverse-selected FAST and SLOW mouse lines. Behav Neurosci, 2002, 116:958

19. Palmer AA, Breen LL, Flodman P, Conti LH, Spence MA, Printz MP. Identification of quantitative trait Loci for prepulse inhibition in rats. Psychopharmacology, 2003, 165:270

20. Palmer AA, Low MJ, Grandy DK, Phillips TJ. Effects of a Drd2 deletion mutation on ethanol-induced locomotor stimulation and sensitization suggest a role for epistasis. Behav Genet, 2003, 33:311

21. Bergstrom HC, Palmer AA, Wood RD, Burkhart-Kasch S, McKinnon CS, Phillips TJ. Reverse selection for differential response to the locomotor stimulant effects of ethanol provides evidence for pleiotropic genetic influence on locomotor response to other drugs of abuse. Alcohol Clin Exp Res, 2003, 27:1535

22. Yonan AL, Alarcón M, Cheng R, Magnusson PKE, Spence SJ, Palmer AA, Grunn A, Juo SHH, Terwilliger JD, Liu J, Cantor RM, Geschwind DH, Gilliam TC. A genomewide screen of 345 families for autism susceptibility loci. Am J Hum Genet, 2003, 73:886

23. Yonan AL, Palmer AA, Smith KC, Feldman I, Lee HK, Yonan JM, Fischer SG, Pavlidis P, Gilliam TC. Bioinformatic approach to search for autism candidate genes. Genes Brain Behav, 2003, 2:303

24. Palmer AA, Printz DJ, Butler PD, Dulawa SC, Printz MP. Prenatal protein deprivation in rats induces changes in prepulse inhibition and NMDA receptor binding. Brain Res, 2004, 996:193

25. Palmer AA, Sharpe AL, Burkhart-Kasch S, McKinnon CS, Coste SC, Stenzel-Poore MP, Phillips TJ. Corticotropin releasing hormone overexpression decreases ethanol drinking and increases sensitivity to the sedative effects of ethanol. Psychopharmacology, 2004, 176:386

26. Meyer PC, Palmer AA, McKinnon CS, Phillips TJ. Tolerance, but not cross-sensitization, to allopregnanolone and pentobarbital in ethanol-sensitized DBA/2J mice. Neuroscience, 2005, 131:263

27. Palmer AA, Verbitsky M, Suresh R, Kamens HM, Reed CL, Li N, Burkhart-Kasch S, McKinnon CS, Belknap JK, Gilliam TC, Phillips TJ. Gene expression differences in mice divergently selected for methamphetamine sensitivity. Mamm Genome, 2005, 16:291

28. Veenstra-Vanderweele J, Qaadir A, Palmer AA, Cook EH de Wit H. Association between the casein kinase 1 epsilon gene region and subjective response to d-amphetamine. Neuropsychopharmacology, 2006, 31:1056

29. Yonan AL, Palmer AA, Gilliam TC. Hardy-Weinberg disequilibrium identified genotyping error of the serotonin transporter (SLC6A4) promoter polymorphism. Psych Genet, 2006, 16:31

30. Palmer AA, Lessov-Schlaggar CN, Ponder CA, Phillips TJ. Sensitivity to the locomotor stimulant effects of ethanol and allopregnanolone: a QTL study of common genetic influence. Genes Brain Behav, 2006, 5:506

31. Winawer MR, Kuperman R, Niethammer M, Sherman S, Rabinowitz D, Guell IP, Ponder CA, Palmer AA. Use of chromosome substitution strains to identify seizure susceptibility loci in mice. Mamm Genome, 2007, 18:23

32. Ponder CA, Kliethermes CL, Drew MR, Muller J, Das K, Risbrough VB, Crabbe JC, Gilliam TC, Palmer AA. Selection for contextual fear conditioning affects anxiety-like behaviors and gene expression. Genes Brain Behav, 2007, 6:736

33. Ponder CA, Munoz M, Gilliam TC, Palmer AA. Genetic architecture of fear conditioning in chromosome substitution strains: relationship to measures of innate (unlearned) anxiety-like behavior. Mamm Genome, 2007, 18:221

34. Manichaikul A, Palmer AA, Saunak S, Broman KW. Significance thresholds for quantitative trait locus mapping under selective genotyping, Genetics, 2007, 177:1963

35. Winawer MR, Makarenko N, Hintz TM, Kamel SM, McCloskey DP, Nair N, Palmer AA, Scharfman HE. Acute and chronic response to pilocarpine in DBA/2J and A/J mice: A foundation for mapping limbic seizure susceptibility genes in sequenced strains. Neuroscience, 2007, 149:465

36. Ponder CA, Huded CP, Munoz MB, Gulden FO, Gilliam TC, Palmer AA. Rapid selection response for contextual fear conditioning in a cross between C57BL/6J and A/J: behavioral, QTL and gene expression analysis. Behav Genet, 2008, 38:277

37. Palmer AA, Brown, AS, Klugewicz D, DeSanti L, Rotrosen J, Butler PD. Prenatal protein deprivation alters

11

dopamine-mediated behaviors and dopaminergic and glutamatergic receptor binding. Brain Res, 2008, 1237:62, PMC2591022

38. Bryant C, Graham M, Distler M, Munoz M, Li D, Vezina P, Sokoloff G, Palmer AA. Role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. Psychopharmacology, 2009, 203:703, PMC2729782

39. Bryant CD, Zhang NN, Sokoloff G, Fanselow MS, Ennes HS, Palmer AA, McRoberts JA. Behavioral differences among C57BL/6 substrains: implications for transgenic and knockout studies. J Neurogenet, 2008, 22:315

40. Williams R, Lim JE, Harr B, Wing C, Walters R, Distler MG, Meike T, Wu C, Wiltshire T, Su AI, Sokoloff G, Tarantino LM, Borevitz JO, Palmer AA. A common and unstable copy number variant is associated with differences in Glo1 expression and anxiety-like behavior. PLoS One, 2009, 4:e4649, PMC2650792

41. Aldinger K, Sokoloff G, Rosenberg D, Palmer AA, Millen K. Genetic variation and population substructure in outbred CD-1 mice: implications for genome-wide association studies. PLoS One, 2009,4:e4729, PMC2649211

42. Dlugos AM, Palmer AA, de Wit H. Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans. J Neural Transm, 2009, 116:323, PMC3653168

43. Bryant CD, Chang HP, Zhang J, Tarantino LM, Palmer AA. A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in mice. Genes Brain Behav, 2009, 8:795, PMC3697834

44. Dlugos AM, Hamidovic A, Palmer AA, de Wit H. Further evidence of association between amphetamine response and SLC6A2 gene variants. Psychopharmacology, 2009, 206:501, PMC4242585

45. Heydemann A, Ceco E, Lim JE, Hadhazy M, Ryder P, Moran JL, Beier DR, Palmer AA, McNally EM. Latent transforming growth factor binding protein 4 modifies muscular dystrophy, J Clin Invest, 2009 119:3703, PMC2786802

46. Dlugos AM, Hamidovic A, Hodgkinson CA, Goldman D, Palmer AA, de Wit H. More aroused, less fatigued: FAAH gene polymorphisms influence acute response to amphetamine. Neuropsychopharmacology, 2010 35:613, PMC2945903

47. McCloskey M, Palmer AA, de Wit H. Are attention lapses related to d-amphetamine liking? Psychopharmacology, 2010 208:201, PMC4004179

48. Hamidovic A, Dlugos A, Skol A, Palmer AA, de Wit H. Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Exp Clin Psychopharmacol, 2009 17:374; PMC2879583

49. Velez L, Sokoloff G, Miczek KA, Palmer AA, Dulawa SC. Differences in aggressive behavior and DNA copy number variants between BALB/cJ and BALB/cByJ substrains. Behav Genet, 2010 40:201, PMC3722062

50. Hamidovic A, Dlugos A, Palmer AA, de Wit H. Polymorphisms in Dopamine Transporter (SLC6A3) are Associated with Stimulant Effects of d-Amphetamine: An Exploratory Pharmacogenetic Study Using Healthy Volunteers. Behav Genet 2010 40:255, PMC4454285

51. Hamidovic A, Dlugos A, Palmer AA, de Wit H. Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine. Psychiatric Genet, 2010, 20:85; PMC2875066

52. Cheng R, Lim JE, Samocha KE, Sokoloff G, Abney M, Skol AD, Palmer AA. Genome-wide association studies and the problem of relatedness among advanced intercross lines and other highly recombinant populations. Genetics, 2010, 185:1033; PMC2907190

53. Samocha KE, Lim JE, Cheng R, Sokoloff G, Palmer AA. Fine mapping of QTL for prepulse inhibition in LG/J and SM/J mice using F2 and advanced intercross lines. Genes Brain Behav, 2010, 9:759 PMC3749925

54. Lionikas A, Cheng R, Lim JE, Palmer AA, Blizard DA. Fine-mapping of muscle weight QTL in LG/J and SM/J intercrosses. Physiol Genomics, 2010, 42:33, PMC2957770

55. Swaggart K, Heydemann A, Palmer AA, McNally E. Distinct genetic regions modify specific muscle groups in muscular dystrophy Physiol Genomics, 2011, 43:24, PMC3026347

56. Dlugos AM, Hamidovic A, Hodgkinson C, Shen P, Goldman D, Palmer AA, de Wit H. OPRM1 gene variants modulate amphetamine-induced euphoria in humans. Genes Brain Behav, 2011, 10:199,

12

PMC337737157. Sokoloff G, Parker CC, Lim JE, Palmer AA. Anxiety and Fear in a cross of C57BL6/J and DBA2/J mice:

mapping overlapping and independent QTL for related traits. Genes Brain Behav, 2011, 10:604. PMC3308133

58. Li D, Herrera S, Bubula N, Nikitina E, Palmer AA, Hanck DA, Loweth JA, Vezina P. Casein kinase 1 enables accumbens amphetamine-induced locomotion by regulating AMPA receptor phosphorylation. J Neurochem, 2011, 118(2):237, PMC3129449

59. Kärst S, Cheng R, Schmitt AO, Yang H, Pardo-Manuel de Villena F, Palmer AA, Brockmann GA. Genetic Determinants for Intramuscular Fat Content and Water Holding Capacity in Mice Selected for High Muscle Mass, Mamm Genome, 2011, 22:530; PMC3318964

60. Philip VW, Sokoloff G, Ackert-Bicknell C, Striz M, Branstetter L, Beckmann MM, Spence JS, Naswa S, Jackson BL, Galloway LD, Barker P, Wymore AM, Hunsicker PR, Durtschi DC, Shaw GS, Shinpock S, Manly KF, Miller DR, Donahue K, Culiat CT, Churchill GA, Lariviere WR, Palmer AA, O'Hara B, Voy BH, Chesler EJ. Genetic analysis in the Collaborative Cross breeding population: Heritability, genetic correlation and QTL mapping, Genome Res, 2011 21:1223; PMC3149490

61. Parker CC, Cheng R, Lim JE, Skol AD, Abney M, Palmer AA. Fine-mapping alleles for body weight in LG/J × SM/J F₂ and F(34) advanced intercross lines. Mamm Genome, 2011, 22:563; PMC3308133

62. Cheng R, Abney, M, Palmer AA, Skol A. QTLRel: an R Package for Genome-wide Association Studies in which Relatedness is a Concern. BMC Genet, 2011, 12(1):66, PMC3160955

63. Winawer MR, Seal SR, Phillips AG, Rabinowitz D, Palmer AA. Mapping a Mouse Limbic Seizure Susceptibility Locus on Chromosome 10, Epilepsia, 2011, 52(11):2076, PMC3346290

64. Parker CC, Cheng R, Sokoloff G, Palmer AA. Genome-wide association for methamphetamine sensitivity in an advanced intercross mouse line, Genes Brain Behav, 2012, 11(1):52, PMC3368015

65. Savic D, Distler MG, Sokoloff G, Shanahan NA, Dulawa SC, Palmer AA, Nobrega MA. Modulation of Tcf7l2 expression alters behavior in mice. PLoS One, 2011, 10(6):e26897, PMC3203170

66. Bryant CD, Parker CC, Zhou L, Olker C, Chandrasekaran RY, Wager TT, Bolivar VJ, Loudon AS, Vitaterna MH, Turek FW, Palmer AA. Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids Neuropsychopharmacology, 2012, 37(4):1026, PMC3280656

67. Parker CC, Cheng R, Sokoloff G, Palmer AA. Genome-wide association for fear conditioning in an advanced intercross mouse line, Behav Genet, 2012, 42(3):437, PMC3351497

68. Carroll AM, Palmer AA, Lionikas A. QTL analysis of the properties of soleus muscle fibers in a cross between LG/J and SM/J mouse strains. Front Genet, 2011, 2:99, PMC3262224

69. Bartnikas TB, Parker CC, Cheng R, Campagna DR, Lim JE, Palmer AA, Fleming MD. Quantitative trait loci for murine red blood cell parameters in strain LG/J and SM/J F2 and advanced intercross lines. Mamm Genome, 2012, 23(5-6):356, PMC3358495

70. Svenson KL, Gatti DM, Valdar W, Welsh CE, Cheng R, Chesler EJ, Palmer AA, McMillan L, Churchill GA. High-resolution genetic mapping using the Mouse Diversity outbred population. Genetics, 2012, 190(2):437, PMC3276626

71. Bryant CD, Kole LA, Guido MA, Sokoloff G, Palmer AA. Congenic dissection of a major QTL for methamphetamine sensitivity implicates epistasis, Genes Brain Behav, 2012, 11(5):623, PMC3691852

72. Distler MG, Plant LD, Sokoloff G, Hawk AJ, Aneas I, Wuenschell GE, Termini J, Meredith SC, Nobrega MA, Palmer AA. Glyoxalase 1 increases anxiety by reducing GABAA receptor agonist methylglyoxal. J Clin Invest, 2012, 122(6):2306, PMC3366407

73. Bryant CD, Kole LA, Guido MA, Cheng R, Palmer AA. Methamphetamine-induced conditioned place preference in LG/J and SM/J mouse strains and an F45/F46 advanced intercross line. Front Genet, 2012, 3:126, PMC3393886

74. Hart AB, Engelhardt BE, Wardle MC, Sokoloff, G, Stephens M, de Wit H, Palmer AA. Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13), 2012, PLoS ONE, 7(8): e42646, PMC3429486

75. Wardle, MC, Hart AB, Palmer AA, de Wit H. Does COMT genotype influence the effects of d-amphetamine on executive functioning? Genes Brain and Behavior, 2012, 12(1):13-20, PMC3553317

76. Cheng R, Palmer AA. A simulation study of permutation, bootstrap, and gene dropping for assessing

13

statistical significance in the case of unequal relatedness. Genetics, 2013, 193(3):1015-8 PMC358398977. Distler MG, Opal M, Dulawa, SC, Palmer AA. Assessment of behaviors modeling aspects of

schizophrenia in Csmd1 mutant mice, 2012, PLoS ONE, 7(12): e51235, PMC352422578. Hart AB, de Wit H, Palmer AA. Candidate gene studies of intermediate phenotypes: failure to replicate.

Neuropsychopharmacology, 2013, 38(5):802-16, PMC367199879. Distler MG, Gorfinkle N, Papale LA, Wuenschell GE, Termini J, Escayg A, Winawer, MR, Palmer AA.

Glyoxalase 1 and its substrate methylglyoxal are novel regulators of seizure susceptibility. Epilepsia, 2013, 54(4):649, PMC3618549

80. Baggott MJ, Childs E, Hart AB, de Bruin E, Palmer AA, Wilkinson JE, de Wit H. Psychopharmacology of theobromine in healthy volunteers. Psychopharmacology, 2013, 228(1): 109, PMC3672386

81. Richards JB, Lloyd DR, Kuehlewind B, Militello L, Paredez M, Solberg-Woods, L, Palmer AA. Strong genetic influences on measures of behavioral-regulation among inbred rat strains. Genes Brain Behav, 2013, 12(5):490, PMC4425401

82. Coyner J, McGuire JL, Parker CC, Ursano RJ, Palmer AA, Johnson LR. Mice selectively bred for High and Low fear behavior show differences in the number of pMAPK (p44/42 ERK) expressing neurons in lateral amygdala following Pavlovian fear conditioning, Neurobiol Learn Mem, 2013, 112:195, PMC Journal – In Process

83. Parker CC, Sokoloff G, Leung E, Kirkpatrick S, Palmer AA. A large QTL for fear and anxiety mapped using an F2 cross can be dissected into multiple smaller QTLs, Genes Brain Behav, 2013, 12(7):714, PMC3947048

84. McGuire JL, Bergstrom HC, Parker CC, Le T, Morgan M, Tang H, Selwyn R, Silva A, Choi K, Ursano R, Palmer AA, Johnson LR. Traits of Fear Resistance and Susceptibility in an Advanced Intercross Line, European Journal of Neuroscience, 2013, 38(9):3314, PMC Journal – In Process

85. Cheng R, Parker CC, Abney M, Palmer AA. Practical considerations regarding the use of genotype and pedigree data to model relatedness in the context of genome-wide association studies, G3, 2013, 3(10):1861, PMC3789811

86. Fitzpatrick CJ, Golpalakrishnan S, Cogan ES, Yager LM, Meyer PJ, Lovic V, Saunders BT, Parker CC, Gonzales NM, Aryee E, Flagel SB, Palmer AA, Robinson TE, Morrow JD. Variation in the Form of Pavlovian Conditioned Approach Behavior among Outbred Male Sprague-Dawley Rats from Different Vendors and Colonies: Sign-Tracking vs. Goal-Tracking. PLoSONE, 2013, 8(10):e75042, PMC3787975

87. Li Y, Cheng R, Spokas KA, Palmer AA, Borevitz J. Genetic Variation for Life History Sensitivity to Future Warming in Arabidopsis thaliana. Genetics, 2014, 196(2):569, PMC3914627 (Issue highlight and also included in 2014 Genetics spotlight booklet)

88. Wang T, Han W, Wang B, Jiang Q, Solberg-Woods L, Palmer AA, Chen H. Propensity for social interaction predicts nicotine reinforced behaviors in outbred rats. Genes Brain Behav, 2014, 13(2):202, PMC3934210

89. Winawer MR, Klassen TL, Teed S, Shipman M, Leung EH, Palmer AA. A locus on mouse Ch10 influences susceptibility to limbic seizure severity: fine mapping and in silico candidate gene analysis, Genes Brain Behav, 2014, 14(3): 341, PMC3947448

90. Hart AB, Gamazon ER, Engelhardt BE, Skalr P, Hultman C, Sullivan PF, Neale B, Faraone SV, Psychiatric Genomics Consortium: ADHD Subgroup, de Wit H, Cox NJ, Palmer AA. Genetic variation associated with the euphorigenic effects of d-amphetamine is also associated with diminished risk for schizophrenia and ADHD. PNAS, 2014, 11(16):5968, PMC4000861

91. Swaggart KA, Demonbreun AR, Vo A, Swanson K, Kim E, Fahrenbach JP, Holley-Cuthrell J, Eskin A, Chen Z, Squire K, Heydemann A, Palmer AA, Nelson SF, McNally EM. Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair, PNAS, 2014, 111(16):6004, PMC4000833

92. Zhou L, Bryant CD, Loudon A, Palmer AA, Vitaterna MH, Turek FW. The circadian clock gene Csnk1e regulates REM sleep amount and NREM sleep architecture in mice. Sleep, 2014, 37(4):785, PMC3972422

93. Carbonetto P, Cheng R, Parker CC, Blizard DA, Palmer AA, Lionikas A. Discovery and refinement of muscle weight QTLs in B6 x D2 advanced intercross mice. Physiological Genomics, 2014, 46(16):571, PMC4137148

14

94. Sittig L, Jeong C, Tixier E, Davis J, Barrios Camacho C, Palmer AA. Phenotypic instability between the near isogenic substrains BALB/cJ and BALB/cByJ. Mammalian Genome, 2014, 25(11-12):564, PMC4241159

95. Gatti, DM, Svenson KL, Shabalin A, Wu LY, Valdar W, Simecek P, Goodwin N, Cheng R, Pomp D, Palmer AA, Chesler EJ, Broman KW, Churchill GA. Quantitative Trait Locus Mapping Methods for Diversity Outbred Mice. 2014, G3 4(9):1623, PMC4169154

96. Parker CC, Carbonetto P, Sokoloff G, Park Y, Abney M, Palmer AA. High-resolution genetic mapping of complex traits in a combined analysis of an F2 intercross and an advanced intercross, Genetics, 2014, 198(1):103, PMC4174923

97. Genetics of Personality Consortium, de Moor MH, van den Berg SM, Verweij KJ, Krueger RF, Luciano M, Arias Vasquez A, Matteson LK, Derringer J, Esko T, Amin N, Gordon SD, Hansell NK, Hart AB, Seppälä I, Huffman JE, Konte B, Lahti J, Lee M, Miller M, Nutile T, Tanaka T, Teumer A, Viktorin A, Wedenoja J, Abecasis GR, Adkins DE, Agrawal A, Allik J, Appel K, Bigdeli TB, Busonero F, Campbell H, Costa PT, Davey Smith G, Davies G, de Wit H, Ding J, Engelhardt BE, Eriksson JG, Fedko IO, Ferrucci L, Franke B, Giegling I, Grucza R, Hartmann AM, Heath AC, Heinonen K, Henders AK, Homuth G, Hottenga JJ, Iacono WG, Janzing J, Jokela M, Karlsson R, Kemp JP, Kirkpatrick MG, Latvala A, Lehtimäki T, Liewald DC, Madden PA, Magri C, Magnusson PK, Marten J, Maschio A, Medland SE, Mihailov E, Milaneschi Y, Montgomery GW, Nauck M, Ouwens KG, Palotie A, Pettersson E, Polasek O, Qian Y, Pulkki-Råback L, Raitakari OT, Realo A, Rose RJ, Ruggiero D, Schmidt CO, Slutske WS, Sorice R, Starr JM, St Pourcain B, Sutin AR, Timpson NJ, Trochet H, Vermeulen S, Vuoksimaa E, Widen E, Wouda J, Wright MJ, Zgaga L, Porteous D, Minelli A, Palmer AA, Rujescu D, Ciullo M, Hayward C, Rudan I, Metspalu A, Kaprio J, Deary IJ, Räikkönen K, Wilson JF, Keltikangas-Järvinen L, Bierut LJ, Hettema JM, Grabe HJ, van Duijn CM, Evans DM, Schlessinger D, Pedersen NL, Terracciano A, McGue M, Penninx BW, Martin NG, Boomsma DI. Genome-wide association study identifies novel locus for neuroticism and shows polygenic association with Major Depressive Disorder. JAMA Psychiatry, 2015, 72(7):642, PMC4667957

98. Genetics of Personality Consortium, van den Berg SM, de Moor MH, Verweij KJ, Krueger RF, Luciano M, Arias Vasquez A, Matteson LK, Derringer J, Esko T, Amin N, Gordon SD, Hansell NK, Hart AB, Seppälä I, Huffman JE, Konte B, Lahti J, Lee M, Miller M, Nutile T, Tanaka T, Teumer A, Viktorin A, Wedenoja J, Abecasis GR, Adkins DE, Agrawal A, Allik J, Appel K, Bigdeli TB, Busonero F, Campbell H, Costa PT, Davey Smith G, Davies G, de Wit H, Ding J, Engelhardt BE, Eriksson JG, Fedko IO, Ferrucci L, Franke B, Giegling I, Grucza R, Hartmann AM, Heath AC, Heinonen K, Henders AK, Homuth G, Hottenga JJ, Iacono WG, Janzing J, Jokela M, Karlsson R, Kemp JP, Kirkpatrick MG, Latvala A, Lehtimäki T, Liewald DC, Madden PA, Magri C, Magnusson PK, Marten J, Maschio A, Medland SE, Mihailov E, Milaneschi Y, Montgomery GW, Nauck M, Ouwens KG, Palotie A, Pettersson E, Polasek O, Qian Y, Pulkki-Råback L, Raitakari OT, Realo A, Rose RJ, Ruggiero D, Schmidt CO, Slutske WS, Sorice R, Starr JM, St Pourcain B, Sutin AR, Timpson NJ, Trochet H, Vermeulen S, Vuoksimaa E, Widen E, Wouda J, Wright MJ, Zgaga L, Porteous D, Minelli A, Palmer AA, Rujescu D, Ciullo M, Hayward C, Rudan I, Metspalu A, Kaprio J, Deary IJ, Räikkönen K, Wilson JF, Keltikangas-Järvinen L, Bierut LJ, Hettema JM, Grabe HJ, van Duijn CM, Evans DM, Schlessinger D, Pedersen NL, Terracciano A, McGue M, Penninx BW, Martin NG, Boomsma DI. Meta-analysis of genome-wide association studies for extraversion: Findings from the Genetics of Personality Consortium. Behavioral Genetics, 2016, 46(2):170, PMC4751159

99. VanderBroek L, Acker J, Palmer AA, de Wit H, MacKillop J. Interrelationships between Family History of Substance Misuse, Impulsive Delay Discounting, and Substance Use. Psychopharmacology (Berl), 2016, 233(1):39, PMC4830143

100. Sittig LJ, Carbonetto P, Engel KA, Krauss KS, Palmer AA. Integration of phenotypic association and extant expression QTL data identify candidate transcripts influencing prepulse inhibition in inbred F1 mice, Genes Brain and Behavior, 2015, 15(2):260, PMC4873164

101. Pallares LF, Carbonetto P, Gopalakrishnan S, Parker CC, Ackert-Bicknell CL, Palmer AA, Tautz D. Mapping of craniofacial traits in outbred mice identifies major developmental genes involved in shape determination, PLoS Genetics, 2015, 11(11):e1005607, PMC4629907

102. Castro-Gomes V, Bergstrom HC, McGuire JL, Parker CP, Coyner J, Landeira-Fernandez J, Ursano RS, Palmer AA, Johnson, LR. Dendritic organization of lateral amygdala neurons in fear susceptible and

15

resistant mice Corresponding, Neurobiology of Learning and Memory, 2016, 127:64, PMC Journal – in process.

103. Yazdani N, Parker CC, Shen Y, Reed ER, Guido MA, Kole LA, Kirkpatrick SL, Lim JE, Sokoloff G, Cheng R, Johnson WE, Palmer AA, Bryant CD. Hnrnph1 is a quantitative trait gene for methamphetamine sensitivity. PLoS Genetics, 2015, 11(12):e1005713, PMC4675533

104. McMurray KMJ, Sidhu PS, Cook JM, Arnold LA, Palmer AA. Genetic and pharmacological manipulation of Glyoxalase 1 regulates voluntary ethanol consumption in mice, Addict Biol, 2017, 22(2):381, PMC4917470

105. McMurray KM, Du X, Brownlee M, Palmer AA. Neuronal overexpression of Glo1 or amygdalar microinjection of methylglyoxal is sufficient to regulate anxiety-like behavior in mice. Behav Brain Res, 2016, 15(301):119, PMC4728018

106. Smith CT, Weafer J, Cowan RL, Kessler RM, Palmer AA, de Wit H, Zald D. Individual Differences in Timing of Peak Positive Subjective Responses to d-Amphetamine: Relationship to Pharmacokinetics and Physiology. J Psychopharm, 2016, 30(4):330, PMC5049703

107. King, C, Palmer AA; Solberg Woods L, Hawk L; Richards J, Meyer P. Premature responding is associated with approach to a food cue in male and female heterogeneous stock rats. Psychopharmacology, 2016, 233(13):2593, PMC5025873

108. Young EE, Bryant CD, Lee SE, Peng X, Cook B, Nair HK, Dreher KJ, Zhang X, Palmer AA, Chung JM, Mogil JS, Chesler EJ, Lariviere WR. Systems genetic and pharmacological analysis identifies candidate genes underlying mechanosensation in the von Frey test. Genes Brain Behav, 2016, 15(6):604, PMC4955286

109. Parker CC, Gopalakrishnan S, Carbonetto P, Gonzales NM, Leung E, Park YJ, Aryee E, Davis J, Blizard DA, Ackert-Bicknell CL, Lionikas A, Pritchard JK, Palmer AA. Genome-wide association study of behavioral, physiological and gene expression traits in commercially available outbred CFW mice. Nat Genet, 2016, 48(8):919, PMC4963286

110. MacKillop J, Weafer J, Gray J, Oshri A, Palmer A; de Wit H. The latent structure of impulsivity: impulsive choice, impulsive action, and impulsive personality traits. Psychopharmacology, 2016, 233(18):3361, PMC5204128

111. Sittig L, Carbonetto P, Engel KA, Krauss, KS, Barrios-Camach CM, Palmer AA. Genetic Background Limits Generalizability of Genotype-Phenotype Relationships. Neuron, 2016, 91(6):1253, PMC5033712*A Cell Video Abstract (https://www.youtube.com/watch?v=x0wNnN7gEgA) was produced for this article. *A Preview of this article ran in the same issue: Richard A. Miller “Not Your Father's, or Mother's, Rodent: Moving Beyond B6”, Neuron, 2016, 91(6):1185.*This article was selected for a review by Faculty of 1000Prime: Ahmari S: F1000Prime Recommendation of [Sittig LJ et al., Neuron 2016, 91(6):1253-9]. In F1000Prime, 21 Feb 2017.

112. Gao J, Davis LK, Hart AB, Sanchez-Roige S, Han L, Cacioppo JT, Palmer AA. Genome-wide Association Study of Loneliness Demonstrates a Role for Common Variation, Neuropsychopharmacology, 2017, 42(4):811, PMC5312064 *This article was among the 10 most downloaded articles from Neuropsychopharmacology, Feb 2017.

113. Gray JC, Amlung MT, Palmer AA, MacKillop J. Syntax for Calculation of Discounting Indices from the Monetary Choice Questionnaire and Probability Discounting Questionnaire. Journal of the Experimental Analysis of Behavior, 2016, 106(2):156, PMC5042866

114. Yang BZ, Han S, Kranzler HR, Palmer AA, Gelernter J. Sex-specific Linkage Scans in Opioid Dependence. Am J Med Genet B Neuropsychiatr Genet, 2107, 174(3):261-268, PMC5695218

115. Carroll AM, Cheng R Collie-Duguid E, Meharg C, Scholz ME, Fiering SN, Fields JL, Palmer AA, Lionikas A. Fine mapping of genes determining extrafusal fiber properties in murine soleus muscle, Physiological Genomics, 2017, 49(3):141-150, PMC5374456

116. McMurray K, Ramaker M, Barklery-Levison, A, Sidhu P, Elkin P, Reddy MK, Guthrie ML, Cook J, Rawal V, Arnold L, Dulawa SC, Palmer AA. Identification of a novel, fast acting GABAergic anti-depressant. Mol Psych, 2018, 23(2):384-391, PMC5608625*This article was selected for a review by Faculty of 1000Prime: Griebel G.

16

https://f1000.com/prime/727434600?key=QQNPOydb6yLSwJr In F1000Prime, 22 Jun 2017. 117. King CP, Militello L, Hart A, St. Pierre CL, Leung E, Versaggi CL, Roberson N, Catlin J, Palmer AA,

Richards JB, Meyer P. Cdh13 and AdipoQ gene knockout alters instrumental and Pavlovian drug conditioning. Genes, Brain and Behav, 2017, 16(7):686-698, PMC5595635

118. Bidwell LC, Gray JC, Weafer J, Palmer AA, de Wit H, MacKillop J Genetic Influences on ADHD Symptom Dimensions: Examination of A Priori Candidates, Genome-wide Variation, and SNP Heritability, Am J Med Genet B Neuropsychiatr Genet, 2017, 174(4):458-466, PMC5690554

119. Oshri A, Kogan SM, Kwon JA, Wickrama KAS, VanderBroek L, Palmer AA, MacKillop J. Impulsivity as a mechanism linking child abuse and neglect with substance use in adolescence and adulthood, Development and Psychopathology, 2017, 13:1-19, PMC Journal – In Process.

120. Holl K, He H, Wedemeyer M, Clopton L, Wert S, Meckes JK, Cheng R, Kastner A, Palmer AA, Redei E, Solberg Woods LC. Heterogeneous stock rats: a model to study the genetics of despair-like behavior in adolescence, Genes, Brain and Behav, 2018, 17(2):139-148, PMC5836722

121. Gray J, MacKillop J, Weafer J, Hernandez K, Gao J, Palmer AA, de Wit H. Genetic Analysis of Impulsive Personality Traits: Examination of A Priori Candidates and Genome-wide Variation, Psychiatry Res, 2018, 259:398-404, PMC5742029

122. Sanchez-Roige S, Fontanillas P, Elson SL, the 23andMe Research Team, Pandit A, Schmidt E, Forster J, Abecasis GR, Gray JC, de Wit H, Davis LK, MacKillop J, Palmer AA. Genome-wide association study of delay discounting in 23,217 adult research participants of European ancestry. Nature Neuroscience, 2018, 21(1):16, PMC Journal – In Process

123. Weafer J, Gray J, Hernandez K, Palmer AA, MacKillop J, de Wit H. Hierarchical Investigation of Genetic Influences on Response Inhibition in Healthy Young Adults, Experimental and Clinical Psychopharmacology, 2017, 25(6):512-520, PMC5737791

124. de Guglielmo G, Conlisk DE, Barkley-Levenson A, Palmer AA, George O. Inhibition of Glyoxalase 1 reduces alcohol self-administration in dependent and nondependent rats. Pharmacology, Biochemistry and Behavior, 2018, 167:36-41, PMC5866249

125. Barkley-Levenson AM, Lagarda FA, Palmer AA. Glyoxalase 1 (GLO1) inhibition does not alter ethanol’s locomotor effects: implications for the use of GLO1 inhibitors in the treatment of alcoholism. ACER, 2018, 42(5):869-878, PMC5915917

126. Pasman J, Verweij K, Gerring Z, Stringer S, Sanchez-Roige S, Treur J, Abdellaoui A, Nivard MG, Baselmans B, Sheng Ong J, Ip H, van der Zee M, Bartels M, Day D, Fontanillas P, Elson S, The 23andMe Research Team, de Wit H, Davis L, MacKillop J, The Substance Use Disorders Working Group of the Psychiatric Genomics Consortium, The International Cannabis Consortium, Derringer J, Branje S, Hartman C, Heath A, van Lier P, Madden P, Mägi R, Meeus W, Montgomery G, Oldehinkel A, Pausova Z, Ramos-Quiroga J, Paus T, Ribases M, Kaprio J, Boks M, Bell J, Spector T, Gelernter J, Boomsma D, Martin N, Macgregor S, Perry J, Palmer AA, Posthuma D, Munafo M, Gillespie N, Derks E. GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Nature Neuroscience, 2018, 21(9):1161-1170.

127. Walters RK, Polimanti R, Johnson EC, McClintick JN, Adams MJ, Adkins AE, Aliev F, Bacanu SA, Batzler A, Bertelsen S, Biernacka JM, Bigdeli TB, Chen LS, Clarke TK, Chou YL, Degenhardt F, Docherty AR, Edwards AC, Fontanillas P, Foo JC, Fox L, Frank J, Giegling I, Gordon S, Hack LM, Hartmann AM, Hartz SM, Heilmann-Heimbach S, Herms S, Hodgkinson C, Hoffmann P, Hottenga JJ, Kennedy MA, Alanne-Kinnunen M, Konte B, Lahti J, Lahti-Pulkkinen, Ligthart L, Loukola AM, Maher BS, Mbarek H, McIntosh AM, McQueen MB, Meyers JL, Milaneschi Y, Palviainen T, Pearson JF, Peterson RE, Ripatti A, Ryu E, Saccone NL, Salvatore JE, Sanchez-Roige S, Schwandt M, Sherva R, Streit F, Strohmaier J, Thomas N, Wang JC, Webb BT, Wedow R, Wetherill L, Wills AG, 23andMe Research Team, Boardman JD, Chen D, Choi DS, Copeland WE, Culverhouse RC, Dahmen N, Degenhardt L, Domingue BW, Elson SL, Frye MA, Gäbel W, Hayward C, Ising M, Keyes M, Kiefer F, Kramer J, Kuperman S, Lucae S, Lynskey MT, Maier W, Mann K, Männistö S, Müller-Myhsok B, Murray AD, Nurnberger JI, Palotie A, Preuss U, Räikkönen K, Reynolds MD, Ridinger M, Scherbaum N, Schuckit MA, Soyka M, Treutlein J, Witt S, Wodarz N, Zill P, Adkins DE, Boden JM, Boomsma DI, Bierut LJ, Brown SA, Bucholz KK, Cichon S, Costello EJ, de Wit H, Diazgranados N, Dick DM, Eriksson JG, Farrer LA, Foroud TM, Gillespie NA, Goate AM, Goldman D, Grucza RA, Hancock DB, Mullan

17

Harris K, Heath AC, Hesselbrock V, Hewitt JK, Hopfer CJ, Horwood J, Iacono W, Johnson EO, Kaprio JA, Karpyak VM, Kendler KS, Kranzler HR, Krauter K, Lichtenstein P, Lind PA, McGue M, MacKillop J, Madden PAF, Maes HH, Magnusson P, Martin NG, Medland SE, Montgomery GW, Nelson EC, Nöthen MM, Palmer AA, Pedersen NL, Penninx BWJH, Porjesz B, Rice JP, Rietschel M, Riley BP, Rose R, Rujescu D, Shen PH, Silberg J, Stallings MC, Tarter RE, Vanyukov MM, Vrieze S, Wall TL, Whitfield JB, Zhao H, Neale BM, Gelernter J, Edenberg HJ, Agrawal A. Trans-ancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders, Nature Neuroscience, 2018, 21(12):1656-1669

128. Gonzales NM, Seo J, Hernandez-Cordero AI, St. Pierre CL, Gregory JS, Distler MG, Abney M, Canzar S, Lionikas A, Palmer AA. Genome wide association analysis in a mouse advanced intercross line. Nature Communications, 2018, 9(1):5162, PMC6279738

129. Wang T, Han W, Chitre A, Polesskaya O, Solberg-Woods LC, Palmer AA, Chen H. Social behavior and anxiety contribute to nicotine self-administration in adolescent outbred rats. Scientific Reports, 8(1):18069

130. Sanchez-Roige S, Fontanillas P, Elson SL, The 23andMe Research Team, Gray JC, de Wit H, Davis LK, MacKillop J, Palmer AA. Genome-wide association study of Alcohol Use Disorder Identification Test (AUDIT) scores in 20,328 research participants of European ancestry. Addiction Biology, 2019, 24(1):121-131, PMC Journal – In Process.

131. Perez C, Barkley-Levenson A, Dick B, Glatt PF, Martinez Y, Siegel D, Momper JD, Palmer, AA; Cohen SM. A Metal-Binding Pharmacophore Library Yields the Discovery of a Glyoxalase 1 Inhibitor, Journal of Medicinal Chemistry, 2019, 62(3):1609-1625, PMC6467756

132. Linnér RK, Biroli P, Kong E, Meddens SFW, Wedow R, Fontana RA, Lebreton M, Abdellaoui A, Hammerschlag AR, Nivard MG, Okbay A, Rietveld CA, Timshel PN, Tino SP, Trzaskowski M, de Vlaming R, Zünd CL, Bao Y, Buzdugan L, Caplin AH, Chen CY, Eibich P, Fontanillas P, Gonzalez JR, Joshi PK, Karhunen V, Kleinman A, Levin RZ, Lill CM, Meddens GA , Muntané G, Sanchez-Roige S, van Rooij FJ, Taskesen E, Wu Y, Zhang F, 23andMe Research Team, eQTLgen Consortium, International Cannabis Consortium, Psychiatric Genomics Consortium, Social Science Genetic Association Consortium, Auton A, Boardman JD, Clark DW, Conlin A, Dolan CC, Fischbacher U, Groenen PJF, Mullan Harris K, Hasler G, Hofman A, Ikram MA, Jain S, Karlsson R, Kessler RC, Kooyman M, MacKillop J, Männikkö M, Morcillo-Suarez C, McQueen MB, Schmidt KM, Smart MC, Sutter M, Thurik AR, Uitterlinden AG, White J, de Wit H, Yang J, Bertram L, Boomsma D, Esko T, Fehr E, Hinds DA, Johannesson M, Kumari M, Laibson D, Magnusson PKE, Meyer MN, Navarro A, Palmer AA, Pers TH, Posthuma D, Schunk D, Stein MB, Svento R, Tiemeier H, Timmers PRHJ , Turley P, Ursano RJ, Wagner GG, Wilson JF, Gratten J, Lee JJ, Cesarini D, Benjamin DJ, Koellinger P, Beauchamp JP. Genome-wide association analyses of risk tolerance and risky behaviors in over one million individuals identify hundreds of loci and shared genetic influences, Nature Genetics, 2019, 51(2):245-257, PMC6713272

133. MacKillop J, Gray J, J, Weafer J, Sanchez Roige S, Palmer AA, de Wit H. Genetic Influences on Delayed Reward Discounting: A Genome-wide Prioritized Subset Approach. Experimental and Clinical Psychopharmacology, 2019, 27(1):29-37

134. Sanchez-Roige S, Palmer AA, The 23andMe Research Team, Substance Use Disorder Working Group of the Psychiatric Genomics Consortium, Adams MJ, Howard DM, Edenberg HJ, Davies G, Crist RC, Deary IJ, McIntosh AM, Clarke TK. Genome-Wide Association Study Meta-Analysis of the Alcohol Use Disorders Identification Test (AUDIT) in Two Population-Based Cohorts, American Journal of Psychiatry, 2019, 176(2):107-118.

135. Sanchez-Roige S, Fontanillas P, Elson SL, the 23andMe Research Team, Gray JC, de Wit H, MacKillop J, Palmer AA. Genome-wide association studies of impulsive personality traits (BIS-11 and UPPSP) and drug experimentation in up to 22,861 adult research participants identify loci in the CACNA1I and CADM2 genes. Journal of Neuroscience, 2019, in press.

136. Hughson AR, Horvath AP, Holl K, Palmer AA, Solberg Woods LC, Robinson TE, Flagel SB, Incentive salience attribution, "sensation-seeking" and "novelty-seeking" are independent traits in a large sample of male and female heterogeneous stock rats. Scientific Reports, 2019, 9(1): 2351

137. Pabon E, MacKillop J, Palmer AA, de Wit, H. Latent Structure of Risk Perception, Personality and Individual Differences, Experimental and Clinical Psychopharmacology, 2019, in press.

18

138. Abdellaoui A, Sanchez-Roige S, Sealock J, Treur JL, Dennis J, Fontanillas P, Elson S, The 23andme Research Team, Nivard MG, Ip HF, van der Zee M, Baselmans BML, Hottenga JJ, Willemsen G, Mosing M, Yu L, Pedersen NL, Denys D, Amin N, van Duijn CM, Szilagyi I, Tiemeier H, Neumann A, Verweij KJH, Cacioppo S, Cacioppo JT, Davis LK, Palmer AA, Boomsma DI. Phenome-wide investigation of health outcomes associated with genetic predisposition to loneliness, Human Molecular Genetics, in press

139. Jessica Dennis, Julia Sealock, Rebecca Levinson, Eric Farber-Eger, Jacob Franco, Sarah Fong, Peter Straub, Donald Hucks, Wen-Liang Song, MacRae Linton, Pierre Fontanillas, Sarah Elson, Douglas Ruderfer, Abdel Abdellaoui, Sandra Sanchez-Roige, Palmer AA, Dorret Boomsma, Nancy Cox, Guanhua Chen, Jonathan Mosley, Quinn Wells, Lea Davis. Genetic risk for major depressive disorder and loneliness in sex-specific associations with coronary artery disease. Molecular Psychiatry, in press

140. Hernandez Cordero AI, Gonzales NM, Parker CC, Sokoloff G, Vandenbergh DJ, Cheng R, Abney M, Skol A, Douglas A, Palmer AA, Gregory JS, Lionikas A. Genome-wide associations reveal human-mouse genetic convergence and modifiers of myogenesis, CPNE1 and STC2, American Journal of Human Genetics, in press.

Reviews 141. The Complex Trait Consortium. The nature and identification of quantitative trait loci: a community’s

view. Nature Rev Genet, 2003, 4:911142. The Complex Trait Consortium. The collaborative cross, a community resource for the genetic analysis

of complex traits. Nat Genet, 2004, 36:1133143. Yang A, Palmer AA, de Wit H. Genetics of caffeine consumption and responses to caffeine,

Psychopharmacology, 2010, 211(3):245 PMC4242593144. Palmer AA, Dulawa SC. Murine Warriors or Worriers: the Saga of Comt1, B2 SINE Elements and the

Future of Translational Genetics. Front Neurosci, 2010, 4:177, PMC2958038145. Parker CC, Palmer AA. Dark matter: are mice the solution to missing heritability? Front Genet, 2011,

2:32, PMC3268586 146. Johnson LR, McGuire J, Lazarus R, Palmer AA. Pavlovian fear memory circuits and phenotype models

of PTSD, 2011, Neuropharmacology, 2012, 62(2):638, PMC Journal – In Process147. Palmer AA, de Wit H. Translational genetic approaches to substance use disorders: bridging the gap

between mice and humans, Human Genet, 2012, 131(6):931, PMC3352994148. Distler MG, Palmer AA. Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent

advances and mechanistic insights, Front Genet, 2012, 3:250; PMC3500958149. Parker CC, Chen H, Flagel SB, Geurts AM, Richards JB, Robinson TE, Solberg Woods LC, Palmer

AA. Rats are the smart choice: rationale for a renewed focus on rats in behavioral genetics. Neuropharmacology, 2014, 76:205, PMC3823679

150. Cacioppo JT, Cacioppo S, Dulawa SC, Palmer AA. Social neuroscience and its potential contribution to psychiatry, World Psychiatry, 2014, 13(2):131, PMC4102278

151. McMurray KM, Distler MG, Sidhu PS, Cook JM, Arnold LA, Palmer AA. Plant LD. GLO1 inhibitors for neuropsychiatric and anti-epileptic drug development, Biochem Soc Transactions, 2014, 42(2):461, PMC4036232

152. Gonzales NM, Palmer AA. Fine-mapping QTLs in advanced intercross lines and other outbred populations. Mamm Genome, 2014, 25(7-8):271, PMC4126234

153. Sanchez-Roige S, Gray J, MacKillop J, Chen C, Palmer AA. The genetics of human personality. Genes, Brain and Behav, 2018, 17(3):e12439, PMC Journal – In Process

154. Sanchez-Roige S, Palmer AA. Electronic Health Records Are the Next Frontier for the Genetics of Substance Use Disorders. Trends in Genetics, 2019, in press

155. Gray JC, Sanchez-Roige S, de Wit H, MacKillop J, Palmer AA. Genomic Basis of Delayed Reward Discounting. Behavioural Processes, 2019, in press

156. Sanchez-Roige S, Palmer AA, Clarke TK. Recent efforts to dissect the genetic basis of alcohol use and abuse. Biological Psychiatry, in press

Book Chapters157. Palmer AA, Phillips TJ. Quantitative trait locus (QTL) mapping in mice. In: methods for alcohol-related

19

neuroscience research, (Lui Y, Lovinger D, Eds.), CRC Press, Boca Raton, FL, 2002158. Tarantino LM, Reyes TM, Palmer AA. Animal models of prenatal protein malnutrition. In: The Origins of

Schizophrenia (Brown AS, Patterson PH, Eds.), Columbia University Press, New York, NY, 2011159. Hart AB, de Wit H, Palmer AA. Genetic factors modulating the response to stimulant drugs in humans,

In: Current Topics in Behavioral Neurosciences: Behavioral Neurogenetics (Andreas R, John C, Eds.) Springer, Heidelberg, Germany, 2012

160. Mayo LM, Palmer AA, de Wit H. Subjective Drug Effects as Intermediate Phenotypes for Substance Abuse, In: Genetic Influences on Addiction: An Intermediate Phenotype Approach (Munafò M and MacKillop J, Eds.), MIT Press, Cambridge, MA, 2012

161. Parker CC, Palmer AA. Using intermediate phenotypes to bridge the gap between human and mouse genetics, In: Genetic Influences on Addiction: An Intermediate Phenotype Approach (Munafò M and MacKillop J, Eds.), MIT Press, Cambridge, MA, 2012

162. St. Pierre CL, Sharif K, Funsten E, Palmer AA, Parker CC. Methods and Theoretical Approaches: Animal Models and Convergence with Human Data. In: Genes, Brain and Emotions: Interdisciplinary and Translational Perspectives (Miu AC, Homberg JR, Lesch KP, Eds.), Oxford University Press, Oxford, UK, 2018

163. Gray JC, Sanchez-Roige S, Palmer AA, de Wit H, MacKillop J. Genetics of decision making. In: Genes, Brain and Emotions: Interdisciplinary and Translational Perspectives (Miu AC, Homberg JR, Lesch KP, Eds.), Oxford University Press, Oxford, UK, 2018

164. Solberg Woods LC, Palmer AA. Using Heterogeneous Stocks for Fine-Mapping Genetically Complex Traits. In: Rat Genomics: Methods and Protocols. Springer, NY, NY, 2019

165. Ren Y, Palmer AA. The rat as an animal model for behavioral studies. In: Rat Genomics: Methods and Protocols. Springer, NY, NY, 2019

Letters to the Editor166. Palmer AA, Airey DC. Letter to the Editor: Inappropriate choice of the experimental unit leads to a

dramatic overestimation of the significance of quantitative trait loci for prepulse inhibition and startle response in recombinant congenic mice. Neuropsychopharmacology, 2003, 28(4):818

167. Yang A, Childs E, Palmer AA, de Wit H. Letter to the Editor: More on ADORA, Psychopharmacology, 2010, 212(4):699, PMC4243305

Under Review, Submitted, uploaded to Biorxiv, or very nearly submittedGileta AF, Gao J, Chitre A, Bimschleger HV, St. Pierre CL, Gopalakrishnan S, Palmer AA. Adapting genotyping-by-sequencing and variant calling for heterogeneous stock rats. https://www.biorxiv.org/content/10.1101/523043v1

(this section is not up-to-date)

Seminars, Presentations, Invited Lectures, etc. 1992-1993 Speaker, Department of Physiology, Monday Morning Joint Lab Meeting and Journal Club,

William F. Ganong, Organizer, UCSF.

1994-1997 Speaker, Student Organized Neuroscience Journal Club, UCSD.

1995-1999 Speaker, Department of Pharmacology Research Rounds, Palmer W. Taylor, Organizer, UCSD.

1998 Symposium Speaker, Berne Distinguished Lectureship and Mini-Symposium: Genetic Dissection of Complex Cardiac Function, “Rostroventrolateral Projecting and Fos Immunoreactive Neuronal Populations Following Airpuff Startle in SHR and WKY Rats.” Kenneth R. Chien, Chair, Experimental Biology, San Francisco, CA.

1999 Invited Lecture, “Genetic Differences in Autonomic and Behavioral Response to the Airpuff Startle Stimulus.” Richard D. Palmiter, Host, University of Washington.

20

1999 Invited Lecture, “Differential Autonomic and Behavioral Responses to Startle Stimuli in Inbred Rat Strains: Possible Implications for Hypertension and Schizophrenia.” Tamara J. Phillips, Host, OHSU.

2000 Speaker, NIAAA/NIDA, Postdoctoral Training Grant Journal Club, Christopher L. Cunningham, Organizer, OHSU.

2000 Symposium Speaker, “Allopregnanolone and Ethanol: Common Genetic Influences?” 30th Annual Society for Neuroscience Meeting, Session Title: Drugs of Abuse: Alcohol II, Abstract 300.11, New Orleans, LA.

2000 Speaker, Department of Behavioral Neuroscience Faculty/Postdoc Monday Morning Seminar Series, John C. Crabbe, Organizer, OHSU.

2001 Speaker, OSHU, Department of Behavioral Neuroscience Postdoctoral, Seminar Series, “Pharmacological and Genetic Studies of the Relationship Between Ethanol and Allopregnanolone.” Christopher L. Cunningham, Organizer.

2001 Symposium Speaker, The Role of Neurosteroids in Alcohol-Related Behaviors, “Genetic Relationship Between Ethanol- and Allopregnanolone-Induced Locomotor Behavior.” Deborah Finn, Chair, Research Society on Alcoholism, 24th Annual Meeting, Montreal, Canada.

2001 Invited Lecture, Rockefeller University, Laboratory on the Biology of Addictive Diseases, “Ethanol and Allopregnanolone: Pharmacological and Genetic Similarities” Mary Jeanne Kreek, Host.

2001 Slide Talk, “Sensitization to the locomotor stimulant effects of allopregnanolone does not engender cross-stimulation to ethanol.” 31st Annual Society for Neuroscience Meeting, Session Title: Drugs of Abuse: Alcohol III, Abstract 572.7, San Diego, CA.

2002 Slide Talk, “Deletion of the Dopamine D2 Receptor Interacts with Genetic Background to Affect Ethanol-Induced Locomotor Stimulation, Locomotor Sensitization and Grid Test Ataxia.” 32nd Annual Society for Neuroscience Meeting, Session Title: Drugs of Abuse: Alcohol I, Abstract 120.6, Orlando, FL.

2003 Speaker, “Gene Expression in Mouse Lines Divergently Selected for Response to Methamphetamine.” Columbia University Department of Genetics and Development 2003 Retreat, Palisades, NY.

2004 Invited Lecture, University of Chicago, Department of Human Genetics, “Using Selective Breeding to Identify Genes Controlling Variability in Complex Behavioral Traits.” Carole Ober, Host.

2004 Invited Lecture, Columbia University, Sackler Institute for Developmental Psychobiology, “Use of Selective Breeding to Study Complex Traits in Mice.” Christoph Wiedenmayer, Host.

2005 Invited Lecture, New York University, Center for Neural Science “Use of selective breeding, QTL mapping and gene-expression profiling in the search for fear-relevant genes in mice.” Joe LeDoux, Host.

2005 Invited Lecture, Virginia Commonwealth University, Department of Pharmacology, “Using selective breeding to identify genes controlling variability in methamphetamine- and fear-related behaviors.” Kenneth Kendler, Host.

2005 Invited Lecture, University of Cincinnati, Department of Psychiatry, “Using selective breeding to identify candidate genes for methamphetamine-sensitivity and fear-related behavior.” Neil Richtand, Host.

2005 Invited Lecture, Mount Sinai School of Medical, Department of Human Genetics, “Integration of QTL mapping and gene-expression profiling in the search for behaviorally-relevant genes.” Robert J. Desnick, Host.

21

2005 Invited Lecture, New York University, Center for Neural Science, "Integration of selective breeding, QTL mapping and gene-expression profiling in the search for fear-learning genes in mice." Joseph E. LeDoux, Host.

2005 Symposium Speaker, “Short-Term Selective Breeding for Fear Learning.” 4th Annual Meeting of the Complex Trait Consortium, Groningen, The Netherlands.

2005 Invited Lecture, University of Chicago, Department of Evolution and Ecology, “Behavioral genetic studies of methamphetamine sensitivity and fear learning in mice: a QTL/eQTL approach to finding candidate genes.” Justin Borevitz, Host.

2005 Hot Topics Seminar, American College of Neuropsychopharmacology 44th annual meeting, “Casein kinase 1 epsilon modulates sensitivity to stimulant drugs in both mice and humans: a translational Genetic Study.” Larry Siever, Chair, Waikoloa, Hawaii.

2006 Invited Lecture, Rosalind Franklin University of Medicine and Science, Department of Neuroscience “Translational genetic strategy for identifying genes for initial sensitivity to stimulants drugs: a combined QTL/eQTL approach.” Daniel A. Peterson, Host.

2006 Symposium Speaker, Gordon Research Conference on Genes and Behavior, “Use of Genetic Selection and Gene Expression Analysis to Identify Genes and Behaviors Associated with Fear Learning in Mice.” John C. Crabbe, Symposium Organizer.

2006 Invited Lecture, University of Chicago, NIDA Training Grant Seminar, “Translational Genetic Strategy for Identifying Genes for Sensitivity to Stimulant Drugs in Mouse and Man: A Combined QTL/eQTL Approach.” Paul Vezina, Organizer.

2006 Invited Lecture, University of Chicago, Committee on Neurobiology Seminar Series, “Identifying genes that control sensitivity to methamphetamine in mouse & man: A combined QTL/eQTL approach.” Peggy Mason, Organizer.

2006 Symposium Speaker, “A combined QTL/eQTL approach identifies Casein kinase 1 epsilon (Csnk1e) as a candidate gene for stimulant sensitivity in mice and humans.” 5th Annual Meeting of the Complex Trait Consortium, Chappell Hill, North Carolina.

2006 Invited Lecture, “Animal Resources Center Meet the Investigator Seminar” Dr. George Langan, DVM, Organizer.

2007 Invited Lecture, Emory University, Department of Human Genetics “Influence of casein kinase 1 epsilon on sensitivity to methamphetamine in mice and men: a translational genetic study.” David Weinshenker, Host, January 8th 2007.

2007 Invited Lecture, University of Zulia School of Medicine (Venezuela) “Using mice to model behavioral characteristics that are associated with human psychiatric diseases” Gladys Maestre, Host, January 16th, 2007.

2007 Invited Lecture, University of Illinois at Urbana-Champaign, Department of Psychology "Genetic screen for behavioral sensitivity to methamphetamine identifies casein kinase 1 epsilon in both mice and men." Host: Justin Rhodes, January 23rd, 2007.

2007 Symposium Chair and Speaker, Symposium title: “Translational genetic approaches to the study of fear and anxiety”; Talk title “Genetic control of learned fear and innate anxiety-like behavior in mice.” International Behavioral and Neurogenetics Society Annual Meeting, Doorwerth, The Netherlands, May 21-25, 2007.

2007 Symposium Speaker, “Functional studies to investigate the role of casein kinase 1 epsilon (Csn1ke) in the locomotor stimulant response to methamphetamine.” 6th Annual Complex Trait Consortium, Braunschweig, Germany, May 26-29, 2007.

2007 Invited Speaker, for NIDA organized workshop “Addiction, Microarrays, and Gene Discovery”; Talk title “Combination of QTL Mapping and Gene Expression Microarrays to Identify Candidate Genes for Sensitivity to the Acute Effects of Drugs in Mice and Humans”, Washington DC, May 30-June 1, 2007.

22

2007 Symposium Chair and Speaker, Symposium title: “The role of genetics and genomics in understanding fear- and anxiety-like behaviors”; Talk title “Genetic relationship of fear and anxiety, lessons from genetic reference populations and beyond.” International Behavioral Neuroscience Society, Rio de Janeiro, Brazil, June 12-16, 2007.

2007 Symposium Speaker and Substitute Chair, "Mouse QTL and human association study of methamphetamine sensitivity"; Symposium title: "Complex Human Disease Genes: Help from Animal Models", American Society for Human Genetics, San Diego, CA, October 25, 2007.

2008 Invited Speaker, "Mapping Complex Traits in the Mouse: Concepts"; Short Course on the Genetics and Epigenetics of Addiction, National Institute on Drug Abuse, Washington D.C., April 4, 2008.

2008 Symposium Chair and Speaker, "Expression differences in Glo1 among mice are due to a common copy number polymorphism"; Symposium title: "Role of oxidative stress in behavior"; International Behavioral and Nuerogenetics Society, Portland, OR, May 5-9, 2008.

2008 Symposium Speaker, "Interaction of Genetics and Environment: Relevance to Nutrition Research"; Multidisciplinary Workshop on Nutrition, Brain Development and Aging: Genetic, Epigenetics, Diet and Behavior, Kannapolis, NC, May 12-14, 2008.

2008 Symposium Speaker, "Copy number variation causes an eQTL for Glo1 and may underlie differences in anxiety-like behavior in mice Dissection of the expression of fear learning: Fine mapping quantitative trait loci (QTL) underlying components of a polygenic trait.", 7th Annual Complex Trait Consortium, Montreal, Canada, May 31-June 4, 2008.

2009 Minicourse, "Frontiers in genomics and neurogenetics: Putting it all together: translational genetics of stimulant sensitivity", 42nd Annual Winter Conference on Brain Research, Copper Mountain, Colorado, January 24-30, 2009.

2009 Plenary Lecture, "Translational Genetics Approach to Amphetamine Sensitivity", 8th Annual Pharmacogenetics in Psychiatry Meeting, New York, NY, April 17-18, 2009.

2009 Symposium Speaker, "Identifying copy number variants in mice using the Mouse Diversity Array", 8th Annual Complex Trait Consortium, Manchester, UK, May 2-5, 2009.

2009 Invited Participant, “Mouse Evolutionary Genetics Meeting”, Chapel Hill, NC, June 18-19, 2009.

2009 Psychiatry Grant Rounds, "Mickey Mouse to Mankind: Translational Genetic Studies of Stimulant Sensitivity", University of Chicago, May 14, 2009.

2009 Human Genetics Seminar Series, “Behavioral genetics of mice and men”, University of Chicago, May 27, 2009.

2009 Young Scientist Award Talk, “Recombination Happens: my personal journey toward unorthodoxy and self realization”, 11th annual meeting of IBANGS, BioInnovationsZentrum, Dresden, Germany, June 5th-8th, 2009.

2009 Invited Teacher, Genetics and Genomics Course (Graduate student class), Cold Spring Harbor Labs, September 21st, 2009.

2009 Invited Lecture, “Quantitative genetic basis of stimulant sensitivity: use of highly recombinant mice and translation to humans”, Cold Spring Harbor Lab, Host: Josh Dubnau, September 22nd, 2009

2009 IDDRC mini-symposium: “Mouse Models of Neurological and Psychiatric Disorders: From Behavioral Analysis to Neurobiological Mechanisms”, September 30th 2009.

2009 Panelist for BSD/PSD Visiting Committee Meeting, “Behavioral Genetics of Mice and Men”, Chicago, IL, November 17, 2009.

2009 Symposium co-Chair and Speaker, “Molecular and genetic approaches toward understanding behavior”, Molecular Biology Society of Japan, Yokohama, Japan, December 10th, 2009.

23

2009 Invited Lecture, National Institute of Genetics, “Quantitative genetic basis of stimulant sensitivity: use of highly recombinant mice and translation to humans” Mishima, Japan, December 14th, 2009.

2010 Invited Lecture, University of Illinois at Urbana-Champaign, Department of Psychology “Use of highly recombinant mouse populations for forward genetic studies of behavioral and other traits”, February 16, 2010

2010 Discussant (Invited), Gordon Conferences on Genes & Behavior, Ventura, CA, March 14th-19th, 2010.

2010 Symposium Speaker, “Genetic approaches to anxiety in model organisms”, Anxiety Disorder Genetics Recent Discoveries and Future Directions, Washington DC, April 21-22, 2010.

2010 Symposium Speaker and Chair, “Fine mapping of QTLs using an advanced intercross line”, in session “Gene mapping in outbred animals”, Complex Trait Consortium, Chicago, IL, May 7-10, 2010.

2010 Symposium Speaker, “Genetic dissection of anxiety-like behaviors using emergent CC mice”, in session “Behavior genetics analysis in the collaborative cross”, 12th Annual meeting of the International Behavioural and Neural Genetics Society, Halifax, NS, Canada, May 12-16, 2010.

2010 Invited Lecture, “Sensitivity to amphetamine in mice and men”, NIAAA, Laboratory of Neurogenetics, Host: David Goldman, May 25th, 2010.

2010 Invited Lecture, “Intermediate Phenotypes: Genetic Factors Influencing Subjective, Behavioral and Physiological Responses to Amphetamine in Healthy Human Subjects”, NIDA Genetics Consortium, Summer Meeting, Bethesda, MD, May 25th, 2010.

2010 Invited Lecture, “Using genome-wide association analysis in advanced intercross mice and humans to understand behavior”, The Jackson Labs, Host: Elissa Chesler, Bar Harbor, ME, May 27th, 2010.

2010 Satellite Speaker, “Animal to human (and back) translational research in the genetics of drug abuse”, NIDA: Application of Genetic Approaches to Understand Drug Abuse and Addiction Satellite Session, College on Problems of Drug Dependence, Scottsdale, AZ, June 11th, 2010.

2010 Tutorial Speaker, “Genetics of Amphetamine Sensitivity“, National Institute on Drug Abuse, College on Problems of Drug Dependence, Tutorials Workshop 2010, Scottsdale, AZ, June 12th, 2010.

2010 Summer Course co-Organizer and Teacher, “Short Course on Genetics of Addiction” Jackson Laboratory, Bar Harbor, ME, Aug 14-18, 2010.

2011 Invited Lecture, “behavioral pharmacogenomics of mice and men”, Rush University Medical Center, Department of Pharmacology, Host: T. Celeste Napier, April 27th, 2011.

2011 Plenary Speaker, “Using Intermediate Phenotypes to Bridge the Gap Between Human and Mouse Genetics”, for: Center for Contextual Genetics and Prevention Science 2nd Annual Symposium: Unraveling Genetic Influences on Substance Misuse: The Intermediate Phenotype. Organizer: James MacKillop, June 23-24, 2011.

2011 Summer Course co-Organizer and Teacher, “Short Course on Genetics of Addiction” Jackson Laboratory, Bar Harbor, ME, Aug 14-19, 2011.

2011 Speaker, “Methylglyoxal is a novel endogenous GABA-A receptor partial agonist: from genetic association to mechanistic insight”, University of Chicago Annual Neuroscience Retreat, Starved Rock, Illinois, Sep 14-15, 2011.

2011 Invited Lecture, "Behavioral, pharmacology and genetics: together at last!”, University of Illinois at Chicago, Department of Psychology, Host: Mitchell Roitman, Chicago, IL, Sep 27, 2011.

2011 Invited Lecture, “Internet impulsivity” University of Chicago, Decision research retreat, Organizer: Harriet de Wit, Oct 27, 2011.

24

2011 Invited Lecture, “Behavioral genetic studies in mice: new populations, new tools, and the identification of a novel GABAergic agonist.” University of Tennessee Health Science Center, Host: Robert Williams, Nov 7-8. 2011.

2012 Invited Lecture, “Tomorrow’s outbred mice, the genetics of amphetamine-induced euphoria, and why some mice are more anxious that others.” Oregon Health & Sciences University, Host: Robert Hitzemann, Jan 10, 2012.

2012 Invited Lecture, “Behavioral genetics in mice and men: quantitative studies related to drug abuse and anxiety disorders.” University of Pennsylvania, Host: Julie Blendy, Jan 20, 2012.

2012 Discussant (Invited), Gordon Conferences on Genes & Behavior, Galveston, TX, March 18th-23rd, 2012

2012 Invited Lecture, “Behavioral genetics of complex behavioral traits in mice: gene identification and mechanistic studies.” Seattle Children’s Research Institute, Seattle, WA, Host: Nino Ramirez, March 29-30, 2012.

2012 Invited Lecture, “Behavioral genetics of complex traits in mice: gene identification and mechanistic studies.” Vrije Universiteit, Amsterdam, Neatherlands, Host: Sabine Spijker, May 10, 2012.

2012 Symposium co-Chair, “Genetic and Epigenetic Effects on Gene Expression and Behavior in Genetically Complex Populations of Monkeys, Mice, and Flies.” Genes, Brain, and Behavior 2012, Boulder, CO, May 17, 2012.

2012 Web Seminar, “Mouse GWAS and Models of Psychiatric Disorders.” Conte Center for Computational Neuropsychiatric Genomics, June 11, 2012.

2012 Speaker, “From CNV to mechanism: what is Glo1 doing to anxiety and how does it do it?” Complex Trait Community 2012, Paris, France, June 12-15, 2012.

2012 Summer Course co-Organizer and Teacher, “Short Course on Genetics of Addiction” Jackson Laboratory, Bar Harbor, ME, Aug 18-23, 2012.

2012 Invited Lecture, “A Novel Mechanism Underlies the Anxiogenic Effect of the Gene Glo1” Psychiatry Day, University of Chicago, Host: Elliot Gershon, Nov 1, 2012.

2013 Invited Lecture, “Quantitative genetic studies of behavior: methodologies, results and why you should care.” Biopsychology Seminar Series, University of Michigan, Host: Terry Robinson, Feb 5, 2013.

2013 Web Seminar, “Genetic susceptibility to the positive subjective effects of d-amphetamine confers increased risk for psychiatric diseases.” Conte Center for Computational Neuropsychiatric Genomics, Host: Ravi Kumar, Chicago, IL, April 8, 2013.

2013 Invited Lecture, "Is metabolic activity linked to neuronal inhibitory tone and can we exploit such a link for therapeutic purposes?" Epilepsy Research Seminars, Columbia University, Host: Melodie Winawer, New York, NY, April 22, 2013.

2013 Invited Lecture, “Behavioral genetics approaches to psychiatric diseases in mice, rats and men.” Institute for Genomic Biology, University of Illinois Champagne Urbana, Host: Brent Roberts, Champaign, IL, April 26, 2013.

2013 Invited Lecture, “Discovering genes that influence behavior and the challenge of elucidating their mechanism.” Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS, Host: Doug Wright, May 2, 2013.

2013 Symposium Speaker, “Novel Mechanisms in Anxiety and Depression; Mechanistic studies of Glo1 and behavior”, 15th Annual Meeting of the International Behavioural and Neural Genetics Society, Leuven, Belgium, May 20-24, 2013.

2013 Summer Course co-Organizer and Teacher, “Short Course on Genetics of Addiction” Jackson Laboratory, Bar Harbor, ME, Aug 17-21, 2013.

25

2013 Panelist, “What Can You Be with a PhD?” NYU School of Medicine, Host: Jessica Linderman, November 2, 2013.

2013 Student Invited Lecture, “Behavioral Genetic Studies in Mice and Men”, North Carolina State University, Department of Genetics, Host: Megan Garapow, Raleigh, NC, November 25th, 2013.

2013 Invited Lecture, “Behavioral Genetic Studies in Mice and Men”, University of North Carolina, Chapel Hill, Chapel Hill, NC, Host: Lisa Tarantino, November 26th, 2013.

2014 Invited Lecture, “Letters from the trenches: using genetic approaches in mice, rats and humans to gain mechanistic insights into addiction and other psychiatric diseases.” Addiction Seminar, Northwestern University, Chicago, IL, Host: Evan Goulding, February 7, 2014.

2014 Invited Lecture, “Mice, rats, humans, drug abuse, psychiatricgenetics and more”, Washington University St. Louis, Host: Joseph Dougherty, February 20, 2014.

2014 Invited Lecture, “GWAS of behavioral traits in mice, rats and humans: using genetic associations to obtain fundamental insights into the biological bases of behavior” Bioinformatics Seminar Series, UCLA, Los Angeles, CA, Host: Jake Lusis, April 21, 2014.

2014 Platform Presentation, “Genome-wide association study of complex traits in an advanced intercross line of mice” 13th Annual Meeting of the Complex Trait Community, May 19-22, Berlin, Germany.

2014 Invited Lecture, “GWAS and eQTL in outbred laboratory mice” Wild Mouse Workshop, Max-Planck-Institut fuer Evolutionsbiologie, May 23-25, Plön, Germany.

2014 Summer Course co-Organizer and Teacher, “Short Course on Genetics of Addiction” Jackson Laboratory, Bar Harbor, ME, Aug 28-Sep 2, 2013.

2014 Invited Lecture, “Using quantitative genetic studies to understand the brain” Zilkha Neurogenetic Institute Seminar Series, University of Southern California, Host: James Knowles, September 30, 2014.

2014 Seminar Speaker, “Using quantitative genetic studies to understand the brain” UCSD Genetics, Bioinformatics, Systems Biology Seminar Series, Host: Jonathan Sebat, Oct 9, 2014.

2014 Oral Presentation, “Pharmacogenomic Endophenotypes: What Can the Subjective Response to D-Amphetamine Tell Us about Risk for Psychiatric Disorders?” in session “Functional Genomics & Endophenotypes” at the World Congress on Psychiatric Genetics, Copenhagen, Denmark, Oct 14, 2014.

2014 Satellite Symposium, “Using genotype-by-sequencing for GWAS of behavioral traits in mice and rats” in a luncheon sponsored by Illumina at the World Congress on Psychiatric Genetics, Copenhagen, Denmark, Oct 14, 2014.

2014 Invited Lecture, “Quantitative genetic studies of behavior and other traits using mice, rats and humans”, Genome Sciences Seminar Series at the Center for Public Health Genomics (CPHG) at the University of Virginia, Host: Charles Farber, Nov 5th, 2014.

2014 Speaker, “GWAS for behavioral and physiological traits in outbred rats” Rat Genomics and models 2014, Dec 1-4, Hinxton, UK.

2014 Symposium Speaker and co-Chair, “Pharmacogenomic endophenotypes: what can the subjective responses to d-amphetamine tell us about risk for psychiatric disorders?” in the session “Next-generation Phenotyping in Search of Genes for Psychiatric Disorders” at the American College of Neuropsychopharmacology 53rd Annual Meeting, Dec 10, 2014.

2015 Invited Lecture, "Quantitative behavioral genetics: mice, rats and humans” Department of Psychiatry, UCSD, San Diego, CA, Host: Jonathan Sebat, January 20th, 2015.

2015 Invited Lecture, “Quantitative Behavioral Genetics”, Integrative Neuroscience Center for Addictions Seminar Series, UCLA, Los Angeles, CA, Host: David Jentsch, April 2, 2015.

26

2015 Keynote Lecture, “Using quantitative genetic techniques to elucidate the molecular mechanisms of behavior” 1st Finish Symposium of Biological Psychiatry, University of Helsinki, Helsinki, Finland, Host: Iiris Hovatta, May 18, 2015.

2015 Instructor, “Genetics of Addiction” for the Cold Spring Harbor Labs Course on the Cellular Biology of Drug Addiction, August 4-10

2015 Summer Course co-Organizer and Teacher, “Short Course on Genetics of Addiction” Jackson Laboratory, Bar Harbor, ME, August 24-29, 2015.

2016 Invited Lecture, “Quantitative Genetic Studies of Behavior in Mice, Rats and Humans”, Institute for Genomic Medicine, UCSD, January 21, 2016.

2016 Invited Lecture, “GWAS for Behavioral, Physiological and Gene Expression Traits in Mice and Rats, How We Do It and What Do We Learn?”, University of Michigan, Department of Psychiatry, Host: Shelly Flagel, May 4, 2016.

2016 Invited Lecture, “Quantitative Genetic Studies of Behavior in Mice, Rats and Humans”, Virginia Commonwealth University, Department of Pharmacology & Toxicology, Host: Mike Miles, May 5, 2016.

2016 Invited Lecture, “Behavioral genetics: from discovery to translation”, Department of Human Genetics Seminar Series, Emory University, Atlanta, GA, Host: David Weinshenker, October 3, 2016.

2016 Satellite Symposium, “Studying impulsivity, alcoholism and loneliness using in person and internet-based phenotyping”, American Society of Human Genetics, Vancouver, BC, Canada, October 20, 2016. 2016.

2016 Invited Lecture, “Using quantitative behavioral genetics to understand biology”, Department of Psychology, University of California San Barbara, Host: Karen Szumlinski, November 4, 2016.

2016 Platform Presentation, “Genome-wide association study of delay discounting identifies GPM6B and demonstrates co-heritability with smoking”, NIDA Genetics Consortium, Berthesda, MD, December 1, 2016.

2106 Discussant, NIDA Genetics Consortium, Berthesda, MD, December 2, 2016.

2017 Invited Lecture, “Using outbred mice and rats to study the genetic basis of behavioral, physiological and expression traits”, Department of Pharmacology, University of Tennessee Health Sciences Center, Memphis, TN, Host: Hao Chen, January 11, 2017.

2017 Invited Lecture, “Genetic approaches to identifying novel targets for pharmacotherapy”, The Larry Parsons Seminar Series, Addiction Affinity Group, The Scripps Research Institute, La Jolla, CA, Host: Candice Contet, January 13, 2017.

2017 Invited Lecture, “A toolbox and rationale for performing GWAS for behavioral traits in outbred mice and rats”, UCSF Institute for Human Genetics Seminar Series, University of California San Francisco, CA, Host: Lauren Weiss, March 24, 2017.

2017 Symposium Chair and Speaker, “Status update on the NIDA center for GWAS in outbred rats; progress, resources and opportunities” Complex Trait Consortium Meeting, Memphis, TN, June 14, 2017

2017 Session Chair and Speaker, Session title: “New Developments in Fast Acting Antidepressants”; Talk title: “Identification of a Novel, Fast-Acting GABAergic Antidepressant” Molecular Psychiatry Meeting, San Francisco, CA, October 6-8, 2017

2017 Symposium Speaker, “Genetics of the Research Domain Criteria (RDoC): Genome-Wide Association Study of Delay Discounting”, World Congress on Psychiatric Genetics, Orlando, FL, Oct 15, 2017.

27

2017 Invited Lecture, “Using the quantitative genetics toolbox identify new ways to treat mental illness”, University of Utah, School of Medicine Benning Medical Society Lecture Series, Salt Lake City, UT, Host: Clement Chow, November 28, 2017.

2018 Invited Lecture, “Identification of Genetic Variants that Contribute to Compulsive Cocaine Intake in Rats”, NIDA Genetics Consortium Meeting, Bethesda, MD, January 10, 2018.

2018 Keynote Lecture, “Behavioral genetic studies of alcoholism and alcohol related traits using mice, rats, and humans”, University of Texas at Austin, Waggoner Center for Alcohol and Addiction Research 6th Annual Retreat, Hosts: Adron Harris and Robert Messing, March 23, 2018.

2018 Plenary Speaker, “The surprising role of the enzyme Glyoxalase 1 and its substrate methylglyoxal in anxiety, depression and alcohol consumption”, Society for Neuroscience, Oregon and Southwest Washington Chapter, Host: Lawrence Sherman, Portland, OR, April 13, 2018.

2018 Symposium Speaker, “Learning and old dog’s new tricks: the role of Glyoxalase 1 in regulating behavior and GABAergic signaling and how we stumbled across it”, Symposium title: “From gene to function of complex traits: analysis of genes identified in human GWAS and animal models.” Experimental Biology, San Diego, CA, April 22, 2018.

2018 Symposium Speaker, “Using N/NIH heterogeneous stock (HS) rats to study the genetic basis of behavior”, Symposium title: “Complex models, complex disorders”, International Behavioral and Neural Genetics Society (IBANGS), Rochester, MN, May 21, 2018.

2018 Invited Talk, “Rats! Quantitative Behavioral Genetics”, Society for the Quantitative Analyses of Behavior, San Diego, CA, May 25, 2018.

2018 Local Host, Speaker and Discussion Group Leader, “NIDA Genetics Consortium Meeting”, La Jolla, CA, June 16, 2018.

2018 Co-Chair and Discussant, “Translational genetics of alcohol use disorders: multidisciplinary approaches to identifying novel thereapeutic targets” Research Society on Alcoholism, 41st Annual Meeting, San Diego, CA, June 17, 2018.

2018 Symposium Speaker, “Replication of Genome-Wide Association Studies (GWAS) of Behavioral and Physiological Traits in an Advanced Intercross Mouse Line”, Symposium title: “Factors influencing replicability of behavioral neuroscience studies”, International Behavioral Neuroscience Society, Boca Raton, FL, June 30, 2018.

2018 Symposium Speaker, “Using GWAS, eQTL and PrediXcan (aka TWAS) to understand complex behavioral traits in mice and rats”, Bridging molecular genetics with population health to advance precision psychiatry, 6th annual Molecular Psychiatry Association, Kauai, HI, September 29th, 2018.

2018 Invited Talk, “Ratification of network research (aka using rats as a model system)", Cell Mapping Symposium, Sanford Consortium for Regenerative Medicine, October 29, 2018.

2019 Invited Talk, “Update on HS rats”, International Rat Omics Consortium (IROC) Meeting, Bethesda, MD, Jan 13, 2019.

2019 Invited Talk, “Genetics of novelty seeking and propensity for drug abuse in outbred rats”, NIDA Genetics Animal Models Consortium Meeting, Bethesda, MD, Jan 16, 2019.

2019 Invited Lecture, “Genetic approaches to understanding the biological basis of behavior”, UCLA, Integrative Center for Neurogenetics, Host: Carrie Bearden, Feb 14, 2019.

2019 Invited Talk, “Genetic approaches to understanding the biological basis of behavior”, 23andMe, Mountain View, CA, Feb 20, 2019.

2019 Oral Paper Podium Presentation, “Collaboration with 23andMe to study the genetic basis of impulsivity: implications for smoking”, in session “Genetic basis of addiction and tobacco-related

28

diseases”, Society for Research on Nicotine and Tobacco 25th Annual Meeting, San Francisco, CA, Feb 21, 2019.

2019 Lecture, “Genetic basis of substance use disorders”, UCSD Department of Psychiatry 50th Anniversary Research Seminar, La Jolla, CA, April 5, 2019.

2019 Seminar Speaker, “Using genome wide association studies in mice, rats and humans to gain molecular insights into behavioral and physiological traits”, PRISM Lecture Series:  Progress in the Science of Medicine, Host: Mohat Jain, La Jolla, CA, April 8, 2019.

2019 Symposium Speaker, “First five years of the NIDA Center for GWAS in Outbred Rats”, 17th Annual Complex Trait Consortium Meeting, La Jolla, CA June 8, 2019.

2019 Symposium Speaker, “Dissecting the genetics of alcohol consumption and alcohol misuse and overlap with alcohol”, Session Title “Genome-wide association study findings inform the relationship between heavy drinking and alcohol use disorder”, Organizer/chair: Henry Kranzler, 42nd Annual RSA Scientific Meeting, Minneapolis, MN, June 23, 2019.

2019 Discussant, “Increasing model organism biological diversity for translational- and discovery-based substance abuse research”, Organizer/chair: Sean Farris, 42nd Annual RSA Scientific Meeting, Minneapolis, MN, June 26, 2019.

Supervision, Mentorship and Training of StudentsHigh School Summer Students Ben Postone 2008

Loren Kole 2009

Colin Walker 2010

Emily Tixier 2010

Miranda Scarlata 2014

Daniel Liu 2017

Eden Deng 2019

Undergraduates and Post-baccalaureate Students John Pac 1995-1996

Aziz Mottiwala 1997-1998 (co-author paper)

Mark N. Miller 2000 (co-author paper)

Michelle R. Moyer 2001 (co-author paper)

Kaitlin E. Samocha 2005-2010 (first author paper, co-author paper; undergraduate honors thesis)

Richard Williams IV 2006-2007 (first author paper)

Chetan Huded 2006 (co-author paper)

Andrew Lee Chen 2006-2007

Melissa Graham 2007-2009 (co-author paper)

Ben Cheng 2006-2009

Qian Zhang 2008

Stacey Kirkpatrick 2008-2010 (co-author paper)

Michael Guido 2009-2012 (co-author 2 papers)

Emily Leung 2009-2013 (co-author 2 papers; undergraduate honors thesis)

Loren Kole 2010-2011 (co-author 2 papers)

29

Elizabeth Wagner 2010-2011

Emily Tixier 2011-2014 (co-author paper)

Marie Wu 2011 (co-author paper)

Naomi Gorfinkle 2011-2013 (co-author paper)

Yeonhee Park 2011-2014 (co-author paper)

Alexandra Dattilo 2011-2012

Joe Davis 2011-2012 (co-author paper)

Camila Barrios-Camacho 2013-2014 (co-author paper)

Celine St. Pierre 2013-2014 (undergraduate honors thesis)

Kyle Engel 2013-2105

Kate Krauss 2013-2015

Brittny Bloomenstiel 2014-2015

Phillip Stephens 2014-2014

Charissa Newkirk 2014-2105

Elizabeth Joyce 2014-2015

Alisha Ho 2014-2015

Shibani Chettri 2015

Kathy Zhou 2015

Rachael Maguire 2015

Africa McLeod 2015

Elizabeth Lipschultz 2015-2016

Frances Lagarda 2016-current

Nishant Mysore 2016-2017

Jazlene Mallari 2017-current

John Shin 2017-current

Fangchao He 2017-current

Yuya Zhao 2017-current

Prajval Iyer 2017-current

Amy Lee 2017-current

Alejandra Nicanor 2017-current

Nilgoun Farhadi 2019-current

Graduate Students (rotations)Forrest Gulden 2006 (rotation; 1 co-authorship)

Jin Zhang 2007 (rotation; 1 co-authorship)

Carolyn Cain, PhD 2008 (rotation)

Sruthi Swaminathan, PhD 2008 (rotation)

Ryan Walters 2008 (rotation; 1 co-authorship)

Tim Looney, PhD 2008 (rotation)30

David Rosenberg 2008-2010 (withdrawn; 1 co-authorship, worked several years as a computer programmer, will enter med school fall 2016)

Jessica Koranda 2009 (rotation)

Zach Weiler 2012 (rotation)

Choongwon Jeong 2012 (rotation)

Anya Bershad 2012 (rotation)

Dana Simmons 2013 (rotation)

Charles Czysz 2014 (rotation)

Katie Long 2014 (rotation)

Katie Mika 2014 (rotation)

Shannan McClain 2016 (rotation)

Cedric Snethlage 2017 (rotation)

Chris Park 2017 (rotation)

Christine Liu 2017 (rotation)

Graduate Students Amanda L. Yonan, PhD 2002-2005 (co-mentor; defended; 3 first author; now Lecturer II at University of

Nevada, Reno)

Rathi Suresh, PhD 2003-2007 (co-mentor; defended; co-authorship; now Associate Partner at Blueprint Research Group)

Christine A. Ponder, PhD 2003-2007 (co-mentor; defended; 3 first author and 2 co-authorships; currently Director, Office of Postdoctoral Affairs, New York University)

Margaret Distler, MD, PhD 2008-2012 (defended; 4 first author and 3 co-authorships, now psychiatric resident at UCLA)

Amy Hart, PhD 2009-2013 (defended; 3 first author and 2 co-authorships; 2013-15 postdoc at U Penn with Hank Kranzler; 2015- Scientist, Network Pharmacology Johnston & Johnston)

Natalia Gonzales, PhD. 2011-2017 (defended, awarded F31 in 2014, 2 first author and 2 co-authorships, currently project scientist at University of Chicago)

Katherine M. Johnson, Ph.D. 2012-2015 (defended; name changed to Katherine M. J. McMurray in 2013, now postdoc at University of Cincinnati)

Alex Gileta. Ph.D. 2013-2018 (defended, now doing clinical genetics fellowship at the University of Chicago)

Xinzhu Zhou 2015-current

Graduate Students (thesis committees)Nancy Shanahan (U Chicago; CON) 2007-2011 (chair)

Russ Bainer (U Chicago; HG) 2008-2012 (chair)

Alisha Epps (Emory U) 2008-2012

Kayleigh Swaggart (U Chicago; HG) 2010-2013 (chair)

Kay-Marie Lamar (U Chicago; HG) 2011-2014 (chair)

Lili Zhou (Northwestern U) 2011-2012

Mark Opal (U Chicago; CON) 2011-2013

31

Traci Viinanen (U Chicago; E&E) 2012-2015

Leah Mayo (U Chicago; CON) 2013-2105 (chair)

Summer Thompson (U Chicago; CON) 2013-2017

Bryan Pavlovic (U Chicago; HG) 2014-2015 (chair)

Andy Vo (U Chicago; HG) 2014-2015 (chair)

Terry Solomon (UCSD; BMS) 2016-2018

Danny Antaki (UCSD; BMS) 2017-2018

Shubham Saini (UCSD; CS&E) 2019-current

Postdoctoral FellowsPei-Chun Chen, Ph.D. 2006-2007 (Currently Assistant Professor at National Cheng Kung University)

Jackie Lim, Ph.D. 2006-2008 (most recent position: Research Scientist at Duke University)

Ney Alliey- Rodriguez, M.D. 2007 (currently Research Associate (Assistant Professor) at University of Chicago)

Camron D. Bryant. Ph.D. 2007-2012 (awarded F32 in 2009 and K99/R00 in 2011, now Associate Professor (with tenure) in the Department of Pharmacology & Experimental Therapeutics at Boston University School of Medicine; www.bumc.bu.edu/busm-pm/faculty/bryant/)

Riyan Cheng, Ph.D. 2008-2012 (currently Associate Project Scientist at UCSD)

Amy Yang, M.D. 2009-2011 (currently Attending Psychiatrist at Hines VA, Chicago, IL)

Clarissa Parker, Ph.D. 2009-2013 (awarded F32 in 2011, NARSAD grant in 2013, now Assistant Professor of Psychology and Neuroscience at Middlebury College; http://www.middlebury.edu/academics/psych/faculty/node/454157)

Shyam Gopalakrishnan, Ph.D. 2011-2015 (currently Fellow at Natural History Museum of Denmark, Copenhagen University, Denmark)

Peter Carbonetto, Ph.D. 2013-2014 (currently Computational Scientist, Statistics & Genetics Research Computing Center, University of Chicago)

April Williams, Ph.D. 2015-2017 (currently Bioinformatics Analyst at Salk Institute)

Laura Sittig, Ph.D. 2012-2017 (awarded F32 in 2014, NARSAD in 2104, now scientific writer at the University of Utah)

Kayla Chase, Ph.D. 2015-2017 (awarded NARSAD in 2015; currently Research Assistant Professor in the Department of Psychiatry at the Jesse Brown VA Medical Center in Chicago, IL)

Sandra Sanchez-Roige, Ph.D. 2016-2019 (awarded NARSAD in 2018 and TRDRP New Investigator Award in 2019; promoted on April 1, 2019 to Adjunct Assistant Professor, Department of Psychiatry, University of California San Diego)

Yu-yu Ren, Ph.D. 2016-2019 (currently Bioinformatics Scientist at AnaptysBio)

Amanda Barkley-Levenson, Ph.D. 2016-current (awarded F32 in 2016, K99/R00 in 2019)

Amelie Baud, Ph.D. 2017-current

Milad Mortazavi., Ph.D 2019-current

32